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ABSTRACT

THE NEONATAL ANTI-VIRAL RESPONSE FAILS TO CONTROL MEASLES VIRUS
SPREAD IN NEURONS DESPITE INTERFERON-GAMMA EXPRESSION AND A
TH1-LIKE CYTOKINE PROFILE

By
Priya Ganesan
December 2017

Dissertation supervised by Dr. Lauren A. O’Donnell
Neonates are highly susceptible to infections in the central nervous system (CNS) and have a
greater risk of viral infections and encephalopathies. Neurotropic viral infections can lead to
blindness, hearing loss and neurological deficiencies such as cognitive impairment, epilepsy, and
even death in the neonatal and pediatric populations. Viral infections also are hypothesized to
indirectly contribute to neurodegenerative and neuropsychiatric diseases such as Schizophrenia
and Parkinson’s disease later in life due to early neuronal damage or stress. Many diverse viruses
are capable of invading the neonatal CNS including Borna Disease Virus, Coxsackievirus (CV),
Herpes simplex viruses (HSV), and measles virus. Although, we understand that many viruses
can cause CNS disease, the mechanisms of viral pathogenesis in the brain and the character of the
neonatal anti-viral immune response are not well understood. However, it is hypothesized that
neurological damage results from the combined effect of the virus and the immune response.
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Therefore, it is critical to develop immune-mediated strategies to promote viral clearance from the
CNS while preventing neuronal damage or loss. This remains a challenge during neonatal CNS
infections because of the uniquely immature nature of the neonatal immune system and the
sensitivity of developing neurons to inflammation. In order to better understand how the neonatal
immune response behaves in the brain, we use neurotropic measles virus (MV) as a model to
understand the deficits in the neonatal immunity. Measles is a single-stranded, negative-sense
RNA virus that is highly contagious in humans. Typical infection involves inhalation of infected
respiratory droplets, infection of dendritic cells and macrophages in the respiratory tract resulting
in transient immunosuppression, and a characteristic fever and rash. However, in some cases, MV
also causes severe neurological diseases such as Post-infectious encephalomyelitis (PIE), Subacute
sclerosing panencephalitis (SSPE), and Measles inclusion body encephalitis (MIBE). Currently,
there is no cure for these MV-related neurological conditions, which occur overwhelmingly in
newborns and children. Thus, the goal of this project is to define how neonatal immunity responds
to MV infection in the unique microenvironment of the brain.

The role of interferon-gamma (IFN), a key anti-viral cytokine in controlling adult CNS
infections, was explored during a neuronally-restricted MV infection in the neonatal brain. We
hypothesized that neonatal mice would be deficient in either IFN production or in the infiltration
of IFN-producing immune cells in the brain. In order to address this question, we utilized the
CD46+ mouse model, in which the human CD46+ receptor for MV is expressed only in mature
neurons of the CNS. We explored the differences in the neonatal immune response, where the
mice succumb to MV infection, and compared that to the CD46+ adults, which successfully control
MV and survive. Our findings suggest that IFN, which is critical for viral control and survival in
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adults, only delays mortality in CD46+ neonates. The neonatal brains also show the infiltration of
natural killer cells, neutrophils, infiltrating monocytes and T cells in an IFN-independent manner,
all of which are capable of contributing to the IFN pool.

However, neonates and adults

differentially express pathogen recognition receptors (e.g. Toll-like receptors) and Type I
interferons during infection in the CNS, which suggests that the initial recognition of the virus by
the immune system may differ in an age-dependent manner. Both neonates and adults expressed
IFN, CXCL10, IL-1, and IL-1RA, among other cytokines/chemokines. Regardless, CD46+
neonates succumb to infection despite mounting a Th1-like, but apparently defective,
inflammatory response. We further explored whether there are age-dependent differences in IFN
signalling given that both ages of mice expressed this critical cytokine. Both neonatal and adult
CD46+ mice express similar levels of IFN but only adults show robust induction of the IFNresponsive genes CIITA and CXCL9. This suggests that IFN signaling may be defective in the
induction of IFN-responsive genes in neonates compared to adults.

To dissect the role of individual components of the immune system, we utilized CD46+
mice crossed to specific immune knockouts: CD46+/IFN-KO mice, which lack IFN, and
CD46+/RAG2-KO mice, which lack mature B and T cells. We found that neonates lacking IFN
succumbed more rapidly than wildtype CD46+ mice, while neonates lacking mature B and T cells
showed delayed morbidity and mortality. Neonates without IFN show high infiltration of
neutrophils and inflammatory monocytes but similar numbers of NK cell infiltration compared to
CD46+ neonates. CD46+/IFN-KO neonatal brains also show high infiltration of CD4 and CD8 T
cells at the later stages of MV infection. Additionally, IFNα is significantly upregulated in the
absence of IFN in the brain post-MV infection. Thus, compensatory cytokines and high immune
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cell infiltration may contribute to uncontrolled inflammation and earlier death in CD46+/IFN-KO
neonates. CD46+ mice deficient in T-cells and B-cells (CD46+/RAG2-KO) show prolonged
survival and mount a robust IFNβ response post-MV infection. This suggests that the adaptive
immune response may be detrimental during the neonatal period, potentially leading to greater
tissue damage. Additionally, CD46+/RAG2-KO neonates alone upregulate unique genes such as
bone morphogenetic proteins (BMPs), which may mediate neuroprotection. Thus, these results
suggest age-dependent expression of cytokine profiles in the brain and distinct dynamic interplays
between lymphocyte populations and cytokines/chemokines in MV-infected neonates.
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CHAPTER 1: LITERATURE REVIEW
1. Introduction
1.1 Neonatal infections
Although smallpox and polio have been largely eradicated, various pathogens can cause
damage to the fetus in utero and in young children.L Pathogens that can infect during pregnancy
and during the early neonatal period include the TORCH pathogens (Toxoplasma gondii, Rubella
virus, Cytomegalovirus (CMV), and Herpes simplex viruses (HSV)), Treponema pallidum,
Respiratory syncytial virus (RSV), Zika virus and Measles virus (MV) (Adams Waldorf and
McAdams, 2013, Marodi, 2006). Many of these infections are common in developing countries
(MV, Toxoplasma), whereas some infections remain common worldwide (CMV, HSV).
Although, this diverse group of pathogens may have different mechanisms of replication, they
each contribute to greater neuropathology and neurological changes in younger hosts.

MV is a highly transmissible virus with an R0 value of 15, meaning that one infected
person will infect 15 other people on average (Griffin et al. , 2008). MV is associated with high
infant mortality although, it is vaccine-preventable. In 2014, 267,000 measles cases were
reported and 146,000 estimated deaths, mostly in young children worldwide. According to the
CDC, there was a 75% decline in measles deaths from 2000-2013 (15.6 million deaths
prevented). But in 2017, till June 17th, there have been 117 reported cases of MV infection in the
United States (Centers for Disease Control and Prevention, 2017). A two-dose vaccination
approach has made significant strides towards global measles control. However, there is
resurgence in MV and MV-related deaths due to logistical and financial challenges in sustaining
the current mass campaign strategy in developing countries (Shibeshi et al. , 2014). In addition,
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parental concerns about vaccine safety in addition to philosophical and religious objections has
led to a resurgence of MV as an endemic disease in many industrialized nations, despite a lack of
evidence between the MV vaccine and autism (Richard and Masserey Spicher, 2009) (Muscat et
al. , 2009).

Table 1
Virus

CNS pathology

Cytomegalovirus

Encephalitis, epilepsy, blindness, deafness

Herpes Simplex Virus

Encephalitis, blindness, herpetic neuralgia

Zika Virus

Microcephaly, agyria

Eastern equine encephalitis virus

Panencephalitis, meningitis, cerebral edema

West Nile Virus

Encephalitis, meningitis, myopathy, paralysis

Human Immunodeficiency virus

Dementia, loss of motor function, encephalitis,
myelitis

Borna Disease Virus

Schizophrenia, depression

Measles Virus

Encephalitis (PIE, SSPE, MIBE)

Japanese Encephalitis Virus

Seizures, acute flaccid paralysis

Coxsackie B virus

Epilepsy

Chikungunya virus

Altered consciousness, Seizures, Brain lesions
and swelling

Varicella Zoster Virus

Vasculopathy of small and large cerebral vessels

Table 1: Neurotropic Viruses and associated neuropathologies
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Neurons are terminally differentiated, long-lived cells. Neurotropic viruses may spread
by axonal transport and move from neuron to neuron through interconnected synapses
(Ehrengruber et al. , 2002). Certain neurotropic infections can be resolved, but in some cases
excessive or chronic inflammation in the CNS can be have disastrous effects. The virus and/or
the immune response can irreversibly disrupt the complex architecture of the brain. For example,
human infections with variegated squirrel Borna virus-1 show the presence of brain lesions with
edema, necrosis, and glial activation, and in utero infections with CMV are associated with
lissencephaly and enlarged ventricles (Volpe, 2008) (Hoffmann et al. , 2015, Ludlow et al. ,
2016). Thus, viral infections can lead to substantial alterations in the structure and subsequent
function of the brain.

Viral infections in the CNS also are hypothesized to indirectly contribute to
neurodegenerative and neuropsychiatric diseases later in life due to damage from a previous
infection (e.g. schizophrenia, Parkinson’s Disease) (Jang et al. , 2009, Khandaker et al. , 2013,
Landreau et al. , 2012). Infection in the CNS is due to a failure in the immune surveillance
mechanism and is common in immunocompromised hosts (Ito et al. , 2000, McArthur, 2004,
Utley et al. , 1997). Thus, it is apparent that neurotropic viruses cause significant disease in the
neonatal brain, but the functionality of the anti-viral immune response in the brain during the
neonatal period is poorly understood. Therefore, it is essential to understand mechanisms that
contribute to neuropathological and immunopathological alterations post viral entry into the
CNS.
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1.2

Mechanisms of cell death in the CNS
The resolution of infection varies depending on the tissue that is affected and on the type

of invading pathogen (Miller et al. , 2016). We cannot tolerate the loss of non-renewable cells like
neurons compared to lysis of renewable cells such as epithelial cells during infections. For example,
HSV-1 causes severe immune and virus-mediated cell death of epithelial cells (Braaten et al. ,
2005, Jones et al. , 2003, Paludan et al. , 2011). However, the lost cells are readily replaced, as
observed by healing of a cold sore. In contrast, Human herpes virus Type 6 infections cause
seizures and meningoencephalitis in children, which is characterized by neuronal loss with gliosis
and microglial nodules in the temporal cortex (Forest et al. , 2011).

Neuronal loss and neuropathology during CNS infections may occur through direct
infection and cytolysis by the virus, or through the inflammatory strategies that cause immunemediated lysis of the virally-infected cell. In the CNS, a more favorable immune response in the
brain would be non-cytolytic towards infected neurons and maintain neuronal integrity (Miller,
Schnell, 2016). But when lytic approaches occur, such as through granzymes and perforins, they
carry the risk of irreversible damage and cell death to the infected neurons, which could contribute
long-term neurological impairments.

In many adult CNS infection models, the pleiotropic

cytokine interferon gamma (IFN) is key to suppressing viral spread while sparing the infected
neurons through non-cytolytic clearance, thus limiting neuropathology and viral replication
(Burdeinick-Kerr et al. , 2007, Hausmann et al. , 2005, Larena et al. , 2013, Patterson et al. , 2002,
Stubblefield Park et al. , 2011). However, in neonates, viruses often spread rapidly in brain tissue
despite the initiation of an immune response (Hausmann, Pagenstecher, 2005, Kopp et al. , 2014,
Manchester et al. , 1999).
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Although the anti-viral role of many immune cells and factors have been well studied, how
immune cells behave in the brain to mediate non-cytolytic clearance is not as clear. Moreover, the
impact of age on the function of the anti-viral response in the brain is largely undefined. In the
next section, we review the current literature on immune cell function during viral infection and
their roles in the CNS, and highlight any known differences based on the anatomical location of
the infection (brain vs. peripheral organs) and age.

1.3

Immune clearance of neuronal infection

1.3.1 Innate immunity
The innate immune response occurs within minutes to hours after infection or injury, such
as meningitis, stroke or other brain trauma (Reviewed in (Ransohoff and Brown, 2012). It is
characterized by activation of pattern recognition receptors, which are expressed by all cell types
in the brain. Activation of microglia (brain-specific macrophages) causes expression of
proinflammatory mediators (chemokines and cytokines) followed by infiltration of other innate
immune cells such as natural killer cells and neutrophils (Downes and Crack, 2010). The innate
immune response is not antigen-specific, and thus it can be mounted quickly against a variety of
insults.

1.3.2 Pattern recognition receptors (PRRs)
The innate immune system detects a viral infection by PRRs present either on the cell
surface or within intracellular organelles. These PRRs include Toll-like receptors (TLRs), retinoic
acid-induceble gene I-like receptor (RLRs), nucleotide oligomerization domain like receptors
(NLRs), and cytosolic DNA sensor families. During viral infection, the virus replicates in different
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compartments of the cell, where they are detected by the PRRs. These receptors recognize
pathogen-associated molecular patterns (PAMPs) such as 5’ triphosphate RNA, which is not
normally found in host RNA or nucleic acids such as viral DNA or double-stranded RNA
(Reviewed in (Thompson and Whitley, 2011).

RNA viruses, such as measles virus, are recognized by the cytoplasmic PRRs, retinoic acidinduced gene-I (RIGI) and MDA5, and the endosomal TLRs. TLR3, RIG-1, and MDA5 recognize
double stranded RNA (dsRNA) molecules, which can be a replication intermediate or the
functional genome of the virus, depending on the viral life cycle. TLR7/8 and TLR9 recognize
viral single-stranded RNA (ssRNA) and DNA. The activation of these receptors lead to the
induction of Type 1 interferons (IFNs), which are significant early steps in viral control (Akira et
al. , 2006, Takeuchi and Akira, 2009, Yoneyama et al. , 2004, Zalinger et al. , 2015).

A. Toll like receptors (TLRs)
Various forms of viral nucleic acids are detected by TLR3, TLR7, TLR8, and TLR9 and play
key roles in the recognition of viral genetic materials in endolysosomal compartments (Reviewed
in (Lester and Li, 2014). All TLRs share a similar architecture consisting of extracellular leucinerich repeats and a cytoplasmic Toll/Interleukin-1 Receptor (TIR) domain. TLRs are type I
transmembrane protein that traffic between the plasma membrane and endosomal vesicle and
recognize PAMPs in the extracellular environment. TLRs on the plasma membrane recognize
hydrophobic lipids and proteins and those in the endosomes detect nucleic acids (Figure 1). TLR3,
TLR7, TLR8 and TLR9 are endosomal receptors and signal through the adaptor protein myeloid
differentiation primary response gene 88 (MyD88) (Kawai and Akira, 2008). TLR3 utilizes the
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TIR domain containing adaptor inducing interferon-β (Trif) adaptor molecule. TLR3, in particular,
has been shown to be induced by the MV-Edmonston strain in cell lines (Tanabe et al. , 2003).
TLR stimulation leads to macrophage activation, followed by cytokine and chemokine production
and initiation of adaptive immunity. Macrophage activation is defined by expression of major
histocompatibility complex (MHC) class I and II molecules, which is induced by the IFNs that are
triggered by TLR activation (Frei et al. , 2010).

PRRs are expressed by immune cells as well as in the CNS (Suh et al. , 2009). Both neurons
and microglia express TLRs, RIG-1, and MDA5 and thus, play critical roles in the initiation of
innate immunity (Nazmi et al. , 2011). There is evidence that intracellular TLRs in human neurons
mediate viral recognition and initiation of the innate immune response during HSV-1 infection.
Both IFNα and IFNβ are induced during neuronal HSV-1 infection as a result of TLR engagement
(Zhou et al. , 2009). There is conflicting evidence on the functionality and expression of TLRs in
neonates. Some studies suggest that newborns exhibit well developed TLR sensor function.
Healthy children over the first 5 years of life appear to express stable TLRs and downstream
signaling molecules at adult-like levels (Reviewed in (Kollmann et al. , 2012). Other studies
indicate that murine neonatal intestinal epithelial cells fail to express TLR3 in response to rotavirus
infection through post-natal days 1-10, which overlaps with the time points reflected in our studies
(Pott et al. , 2012). Similarly, human cord blood samples do not induce TLR3 in response to
poly(I:C) treatment or HSV activation in comparison to adult NK cells (Slavica et al. , 2013). Thus,
the age-dependent effects of TLR induction and functionality in the neonatal CNS are not well
understood.
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B. Retinoic acid-inducible gene I-like receptors (RLRs)
The RLR family is comprised of MDA-5 and RIGI and sense PAMPs in viral RNA. The
expression of RLRs are low in resting cells but increase during viral infection and due to IFN
exposure (Reviewed in (Loo and Gale, 2011)). MDA5 expression is induced by the virus in cells
without the IFN receptor, indicating that RLR expression is controlled by a direct virus-inducible
signal (Yount et al. , 2007). Various families of virus such as Paramyxoviridae, Rhabdoviridae,
Picornaviridae, and Orthomyxoviridae are recognized by RIGI and MDA5. Viruses such as
Dengue virus, West Nile virus, and Reovirus are recognized by both MDA5 and RIGI. Studies
suggest that mice lacking RIGI or MDA5 receptors are highly prone to RNA viral infections,
highlighting the importance of these proteins in recognizing RNA viruses. (Reviewed in (Loo and
Gale, 2011).

8

RLRs signal through the common adaptor mitochondrial antiviral signaling protein
(MAVS) (Kawai and Akira, 2008). RIG1 and MDA5 share several similarities such as i) Nterminal region consisting of tandem caspase activation and recruitment domains (CARD) ii) a
central DExD/H box RNA helicase domain with the capacity to hydrolyze ATP and to bind and
unwind RNA, and iii) a C-terminal repressor domain (RD) for autoregulation. RIGI is present in
the cytoplasm in resting conditions. During a viral infection, RIGI binds to PAMPs and
undergoes a conformational change to release CARDs from RD. This conformational change
results in formation of dimers in an ATP-dependent manner. The CARDs in the RIGI complex
mediate signalling via mitochondrial antiviral signaling protein (MAVS). MDA5 also signals
through downstream adaptor protein, MAVS, which in turn induces type I IFNs and host defense
gene expression (Reviewed in (Loo and Gale, 2011)). Both TLRs and RLRs lead to activation
NF-κB, MAP kinases and IRF3, resulting in production of pro-inflammatory and anti-viral
response genes (Akira, Uematsu, 2006).

9

Figure 1

Figure 1. TLR signaling
TLRs recognize viral proteins such as dsRNA, ssRNA and CpG DNA and antiviral immune
response is initiated. TLR2 and TLR4 are cell surface receptors and recognize viral proteins.
TLR3, TLR7, TLR8, and TLR9 are intracellular receptors present on the endosomes and
recognize viral dsRNA, ssRNA and unmethylated CpG DNA. All TLRs recruit MyD88 except TLR3.
Both TLR3 and TLR4 recruit adaptor protein TRIF. Both MyD88 and TRIF-dependent signaling
complexes activate transcription factors such as NF-KB, IRF3, and IRF7. Inflammatory cytokines
and chemokine expression is regulated by NF-KB. Whereas IRF3 and IRF7 mediate the
transcription of Type I IFN and type III IFN genes. ((Lester and Li, 2014); Reprinted from TollLike Receptors in Antiviral Innate Immunity, Volume 426, Issue 6, Sandra N. Lester, Kui Li, Pages
1246-1264, 20 March 2014, with permission from Elsevier)
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1.3.3 Type I Interferon
After a virus, has initiated infection in a host cell, the early anti-viral response is started by
sensing of pathogen associated molecular patterns (PAMPs) by pattern recognition receptors
(PRR), which are expressed in all cells. The binding of conserved motifs such as single stranded
RNA (ssRNA), double stranded RNA (dsRNA), and glycoproteins induces the production of the
type I IFNs: IFNα and IFNβ. Type I IFNs are produced by infected cells and act in a paracrine
and autocrine manner through IFNAα/β (IFNAR) receptor. Engagement of IFNα/β with the
cognate receptor results and in phosphorylation of tyrosine kinases (Janus kinases) and tyrosine
phosphorylation of cytoplasmic signal transducer and activator of transcription (STAT1) and
STAT2. Activated heterodimers of STAT1-STAT2 bind to IFN regulatory factor 9 (IRF9) to form
Interferon-stimulated gene factor 3 (ISGF3), which translocates to the nucleus and binds to IFNstimulated response elements within the promoters of IFN-stimulated genes (ISGs). These genes
produce proteins that inhibit viral replication and promote virus clearance. ISGs can directly cleave
viral nucleic acids, trigger apoptosis or autophagy of the infected cell, and upregulate major
histocompatibility complex (MHC) class I expression to mediate CD8 T cell cytotoxicity. Type I
IFNs bind to neighbouring uninfected cells and protect them from infection, thereby containing
the initial spread of the virus. Type I IFNs also contribute to the recruitment of adaptive immune
effectors to infected sites, which further promotes viral clearance (Goodbourn et al. , 2000,
Holmgren et al. , 2015). In canonical type I IFN signalling, JAK/STAT pathway is activated
leading to transcription of ISGs and IFNβ. During viral spread and secondary infection, IFN-β
drives IRF7 gene expression to enable a full type I IFN response (Perry et al. , 2005).
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Infected neurons may secrete type I IFNs, which act in an autocrine and paracrine manner
on other neurons and brain parenchymal cells (Delhaye et al. , 2006). Studies in Theiler’s virus
and La Crosse virus models of CNS infection suggest that type I IFN is produced by infected
ependymal cells, macrophages and neurons; but only 3% of infected neurons express Type I IFN
(Delhaye, Paul, 2006). Other studies with La Crosse virus found that neurons do not express Type
I IFN, but glial cells expressed Type I IFNs (Kallfass et al. , 2012). However, hippocampal neurons
have been shown to express a higher basal level of interferon beta (IFNβ) than peripheral
fibroblasts, suggesting that neurons are capable of expressing Type I IFNs under a variety of
circumstances (Cavanaugh et al. , 2015). Whether virally-infected neurons express Type I IFNs
may then be dependent upon the type of virus that is infecting the cells and the type of PRRs that
detect it.
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Figure 2

Figure 2. Antiviral innate immunity.
Virus (red) infects the host cell (white circle). The virus is recognized by pattern
recognition receptions (PRRs) such as RIGI, MDA5, TLR3 or TLR7. They activate
downstream signaling cascades after they recognize the viral molecular patterns and lead
to the induction of IFNα and IFNβ. Macrophages are innate cells that recognize a foreign
pathogen and can phagocytose the pathogen and release several cytokines.
Macrophages release cytokines that activate Natural killer cells (NKs). NK cells release
IFNγ which further activates the T-cell response (adaptive immunity). NK cells also act
through granzymes and perforin can attack the virally infected cells. Neutrophils, part of
innate immunity release protease and reactive oxygen species during a viral infection.
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1.3.4 Microglia
Microglia and astrocytes are resident cells of the brain that respond immediately to neuronal injury.
Microglia are the resident macrophages of the brain. They are derived from the early yolk sac from
macrophage progenitor cells (Ginhoux et al. , 2010, Kierdorf et al. , 2013). They play critical roles
during normal brain development, disease, injury, and homeostasis. There is negligible infiltration
of peripheral monocytes to the brain parenchyma under physiological conditions and the microglia
population is likely sustained by self-renewal (Ajami et al. , 2007). When microglia undergo
activation, they transform from ramified phenotype to an amoeboid phenotype with greater
motility, migratory, and phagocytic capacities. Activated microglia produce neuroinflammatory
mediators and cellular expansion (Atallah et al. , 2014, Lull and Block, 2010). Depending on the
type of insult, microglia are polarized to M1 or M2 phenotype. M1 are activated or classical
phenotype, produce proinflammatory cytokines such as TNF, IL-6. IL-1β and reactive oxygen
species and nitric oxide. M2 microglia are anti-inflammatory and play a role in tissue repair. In
vitro studies indicate that M1 microglia are neurotoxic. (Fernandes et al. , 2014). The age
dependent differences in microglial phenotype during a neonatal CNS infection are not well
understood.

1.3.5 Neutrophils
Neutrophils are part of the first line of defense and migrate from the bone marrow in response to
chemokines that mediate the inflammatory response. These cells respond to PAMPs via TLRs and
NLRs and are stimulated by cytokines such as TNFα and IFNγ. Activated neutrophils upregulate
expression of CD15 and CD11b, adhesion molecules that help them bind to the endothelium and
migrate into infected tissue (Mantovani et al. , 2011). Neutrophils produce large amounts of
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reactive oxygen species (ROS) and release proteases that are stored in specific granules after
activation. During viral infections, IFNs modulate the neutrophil response to the chemoattractant,
CXCL1, and induce adaptive immunity (Munir et al. , 2011). Additionally, neutrophils are the
dominant immune cell in the brains of mice deficient of IFNγ (Abromson-Leeman et al. , 2004,
Wensky et al. , 2005), suggesting that IFNγ modulates neutrophil migration.

Depending on the severity of infection, neutrophils may contribute to an unfavorable
response. In multiple sclerosis models, neutrophils are among the earliest cells that infiltrate into
the CNS. Depletion of neutrophils are associated with reduction in the severity of the disease in
MS models (Carlson et al. , 2008). Studies in a neurotropic JHM strain of mouse hepatitis virus
(JHMV) indicate that neutrophils and inflammatory monocytes are the first leukocytes to enter the
brain post-infection (Zhou et al. , 2003). If neutrophils are eliminated, JHMV-infected mice
preserve BBB integrity and show reduced infiltration of other immune cells. Thus, these studies
suggest that infiltrating neutrophils may contribute to neuropathology in the CNS.

Neonatal innate immune cells such as neutrophils and monocytes show decreased
chemotaxis, phagocytosis, and microbicidal properties compared to adult cells (Mariscalco et al. ,
1998). The number of polymorphonuclear leukocytes (PMNs)/granulocytes in neonates are higher
than the numbers found in adults (Manroe et al., 1979). Neonatal neutrophils have similar amounts
of myeloperoxidase and defensins, but lower amounts of lactoferrin and elastase. This suggests
that neonatal neutrophils may have quantitative and qualitative deficits that predispose newborns
to infections.

15

1.3.6 Natural killer (NK) cells
NK cells can respond to pathogens by mediating cytotoxicity and producing cytokines
(Vivier et al. , 2008). These lymphocytes are critical players in innate immunity during viral
infections and affect the outcome of adaptive immunity. Several viruses escape cytotoxic T-cells
(CD8+) by decreasing MHC I expression in the infected cell. This prevents the host cell from
presenting viral proteins to virus specific cytotoxic T-cells, but it makes the infected cell prone to
NK cell defenses. NK cell activation is blocked by inhibitory receptors that bind to MHC I. These
receptors are called the Killer Cell Immunoglobulin-like receptor (KIR) family. Therefore, cells
with low MHC I expression, such as due to virus-dependent downregulation, are susceptible to
attack by NK cells. Cytokines such as Interleukin 12 (IL-12) and IL-18 mediate IFNγ production
from NK cells during viral infections (Biron et al. , 1999). NK cells produce cytokines such as
tumour necrosis factor (TNF) and IFNγ and various chemokines during an inflammatory response.
NK cells mediate their anti-viral functions by lysis of infected cells, promoting recruitment of other
non-specific innate cells such as neutrophils and macrophages, and modulate the T-cell and B-cell
response (adaptive immunity) (Ljunggren and Malmberg, 2007).

NK cells mediate protection in several neurotropic virus models such as HSV, Theiler’s
murine encephalomyelitis virus, mouse hepatitis virus (MHV). For example, children with herpes
encephalitis show deficiencies in NK cell function. There is also evidence of NK cells being
neurotoxic as well as neuroprotective (Reviewed in (Poli et al. , 2013)). NK cells are known to not
just promote the T-cell response but also to limit the immune response by killing APCs and
lymphoid cells. In neonates, there are higher numbers of circulating NK cells in the periphery than
in adults, but the neonatal NK cells have limited cytotoxic function (Lee and Lin, 2013). However,
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the role of NK cells in the neonatal brain and how they infiltrate into the CNS are not well
understood.

1.4

Adaptive immunity
The main cells involved in adaptive immunity are antigen-specific lymphocytes, including

the CD4 and CD8 T cells and B-cells. When a virus infects a host cell, it utilizes the protein
machinery of the host cell to synthesize viral proteins. During this process, the viral proteins are
degraded into peptides that will bind to major histocompatibility complex (MHC) class I molecules.
The MHC I/peptide complex will be presented on the surface of the infected cells and CD8+ T
cells specific to the peptide will identify the complex. The CD8 T cells then induce apoptosis of
virally-infected cells through its cytotoxic molecules (Figure 3) (Rosendahl Huber et al. , 2014).
However, in some circumstances, the CD8 T cells may be triggered to release cytokines that do
not kill the infected cell but rather help to initiate an anti-viral program. IFNγ, belonging to Type
II IFN family, is mainly produced by mature CD4 T helper–1 (Th1) cells, but also by CD8 T cells
and NK cells. IFNγ is a key cytokine for mediating non-cytolytic clearance, allowing the infected
cells to intiate an anti-viral program without cell death or lysis.
T cells induce an effective adaptive immune response, particularly an effective induction
of MHC proteins. Type I IFNs contribute to the Th1 skew of naïve T-cells (Hibbert et al. , 2003),
promote CD8 T-cell activity, and thus, promotes the B-cell response by antibody production
(Curtsinger et al. , 2005, Nishikomori et al. , 2002). Depending upon the type and dose of antigen,
T cells often skew towards a Th1, Th2, or a Th17 phenotype (Figure 3). Thus, Th1 cells aid in the
clonal expansion of CD8+ T-cells, specifically through IFN. CD4+ cells can also skew towards
a Th2 phenotype and produce cytokines such as IL-4, IL-5, and IL-21. Th17 cells are a subset of
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CD4+ T cells which produce IL-17 (Reviewed in (Libbey and Fujinami, 2014). In Theiler’s murine
encephalomyelitis virus (TMEV) infection, Th17 cells promotes viral pathogenesis by inhibiting
apoptosis of virally infected cells and decreasing the cytotoxic function of CD8+ T-cell (Hou et
al. , 2009). The other arm of adaptive immunity is the humoral immune response which consists
of antibodies (Abs) specific to virus mediated by B-cells. Activated CD4 T cells will stimulate B
cells that present a matching MHC II/peptide complex to lead to Ab production. These Abs
neutralize extracellular viruses before they can enter a host cell (Rosendahl Huber, van Beek, 2014).

Studies suggest that infiltrating lymphocytes are the main source of critical cytokines in
the brain. In parenchymal cells, IFNγ induces MHC class I (MHC-I) and MHC-II expression,
particularly in microglia (Merrill et al. , 1992, Renno et al. , 1995). T-cells may play either a
pathogenic role or a protective role in neurotropic infections. For example, in Borna virus infection,
infiltrating CD8 T-cells in the absence of IFNγ cause hippocampal neuronal death and neurological
disease in young and old mice. In the presence of IFNγ, virus was cleared from the neurons,
suggesting that IFNγ is neuroprotective factor and limits neuronal loss during the antiviral immune
response in the brain. (Hausmann, Pagenstecher, 2005). CNS MHV infection is controlled by
CD4+ and CD8+ T-cells. They decrease the viral load through IFNγ and cytolytic activity and lead
to viral control and protection (Bergmann et al. , 2004, Parra et al. , 1999, Stohlman et al. , 1998).

In respiratory syncytial virus (RSV) infection, CD8 T-cells and IFNγ are critical for viral
control in adults (Olson et al. , 2008, Olson and Varga, 2007). Whereas, infants with RSV exhibit
a defective CD8 T-cell response, reduced IFNγ production, and an aberrant Th2 skewed response
(Harker et al. , 2010, Larranaga et al. , 2009). Evidence from other peripheral infections shows that
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the neonatal immune response induces a distinct cytokine profile when compared to an adult
response against the same pathogen (reviewed in (Adkins et al. , 2004). Neonatal T cells often
skew towards Th2-like response (including production of IL-4, IL-5, and IL-13) as opposed to a
Th1 response, characterized by the production of IFN and TNF (Zaghouani et al. , 2009). Thus,
in neonates, viruses often spread rapidly in brain tissue despite the initiation of an immune response
(Hausmann, Pagenstecher, 2005, Kopp, Ranaivo, 2014, Manchester, Eto, 1999). During a CNS
infection, one could hypothesize that a Th1 response would be preferred in order to ensure
adequate IFN expression and control viral replication in developing neurons while minimizing
neuronal loss. However, IFN also has been shown to play both neurotoxic and neuroprotective
roles for developing neurons, making the influence of IFN in controlling neonatal infections in
the brain less clear (Mizuno et al. , 2008, O'Donnell et al. , 2015).
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Figure 3.

Figure 3. T-cell subsets. Peptides from pathogens are processed and presented by MHC to
naïve T-cells in the draining lymph node. CD4 T-cell depending on the type of pathogen and
cytokines may skew towards either a Th1, Th2 or a Th17 phenotype. Th1 cells drive clonal
expansion of CD8 T-cell through IFN. Th2 cells drive B-cell expansion via IL-4. Th17 cells secrete
IL-17 and T regulatory (Treg) cells secrete IL-10. (Used with permission (Araya et al. , 2011)
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A. Interferon gamma (IFNγ)
Both innate immune cells such as NK cells and adaptive immune cells such as activated Tcells produce IFNγ during neuronal infections. IFNγ helps to enhance the NK cell and macrophage
response, upregulate MHC II expression on macrophages, and activates CD8+ T-cells. (Biron,
Nguyen, 1999, Heise and Virgin, 1995). Murine CMV and HSV infections are severe in mice
without IFNγ or its receptor (Novelli and Casanova, 2004). This cytokine signals through
Interferon gamma receptor (IFNγR), a multimeric complex composed of two chains, the cellsurface α-chain and a transmembrane β-chain. The α-chain of IFNγR binds IFNγ with high affinity,
triggering its dimerization with the β-chain of IFNγR, and induction of a signaling cascade that
results in that activation of Janus kinase (JAK) and signal transducer and activator of transcription
(STAT) pathway. JAK-1 associates with the IFNγR α-chain while JAK-2 associates with β-chain.
Activation of JAK 1 and 2 leads to the phosphorylation and activation of (STAT)-1α. STAT1
homodimers translocate to the nucleus and binds to gamma-activated sequences (GAS), a specific
DNA response element present in more than 200 IFNγ-responsive genes (Popko, et al., 1997). This
promotes transcription and translation of antiviral proteins against infections or to induce apoptosis
of infected cells (Goodbourn, Didcock, 2000).
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Figure 4. IFNγ signalling
IFNγ binding to the receptor results in the formation of dimers and activation of (JAK-STAT)
pathways. IFNγ mediated CIITA activation, which is a master regulator of Class II MHC expression.
CIITA is a co-activator whose expression is regulated at a transcriptional level. Class II MHC
molecules play a critical role in the immune response in antigen presentation of CD4+ T cells,
resulting in their activation and differentiation.
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B. CIITA (Class II Major Histocompatibility Complex Transactivator
CIITA, a critical regulator of MHC II induction, is an IFN-responsive gene (Reith et al. ,
2005). MHC II is expressed constitutively on antigen presenting cells (APCs) and its expression
is IFNγ-inducible in macrophages, microglia, and endothelial cells (O'Keefe et al. , 2002, Reith,
LeibundGut-Landmann, 2005) (Cullell-Young et al. , 2001). CIITA is the master regulator of class
II gene activation and its expression is regulated at a transcriptional level. Studies suggest that
neonatal macrophages are defective in antigen presentation due to its inability to stimulate MHCII
expression after IFNγ treatment. This impairment is at the transcriptional level due to low
expression of downstream CIITA (Lee et al. , 2001). Such impairments may also occur in the
neonatal CNS during infection. In this dissertation, we explore the role of IFNγ and CIITA
transcription to understand their role in the pathogenesis of a neurotropic measles virus in neonates.
The next section provides an overview of MV pathogenesis in the periphery and the CNS.

1.5 MV pathogenesis
Measles is a negative-sense, double-stranded RNA virus. MV is a member of genus
Morbillivirus belonging to the family Paramyxoviridae (Malvoisin and Wild, 1993). It leads to a
highly contagious disease. Before the introduction of measles vaccine it was one of the most
devastating infections that caused millions of infant deaths worldwide (Moss and Griffin, 2012).
MV is believed to have been established 5000-10000 years ago, when populations reached
sufficient size in Middle Eastern river valley civilization to sustain virus transmission.
Phylogenetic analysis reveals a recent divergence from rinderpest virus that infects cattle in the
11th or 12th century. MV attenuated and killed vaccines were introduced in 1960s after successful
isolation of the virus from tissue culture (Black, 1966). There is no latent or persistent MV
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infection. There is no animal reservoir that maintains virus transmission (Moss and Griffin, 2012).
Thus, the eradication of MV is favored by the monotypic nature of the virus.

1.6 MV spread
MV is efficiently transmitted via the respiratory route by aerosol or respiratory droplets.
MV initiates infection in the respiratory tract where immature pulmonary (DCs) dendritic cells
and alveolar macrophages are the initial cellular target. MV is transmitted to the regional lymph
node (LNs) by migrating infected immune cells. Thus, virus replication and spread occurs from
the lymph nodes and the immune response is initiated (Ludlow et al. , 2013, Mesman et al. ,
2012). The incubation time is about 10 days for the onset of fever and 14 days for the onset of
rash. The symptoms include cough, coryza, fever and white spots in the mouth called Koplik’s
spots. It is then followed by maculopapular rash that starts in the face and neck and spreads to
the rest of the body (Coughlin et al. , 2013, O'Donnell and Rall, 2010). The initial hypothesis
was that MV pathogenesis starts in the respiratory epithelial cells followed by proliferation of
MV in the lymphatic tissue eventually leading to monocyte-mediated viremia. But the SLAM
receptor used by wildtype strains of virus was not expressed in any of these targets, suggesting
the existence of alternative MV receptors that were yet to be discovered (de Swart et al. , 2007).

CD46, CD150 (signaling lymphocyte activation molecule - SLAM) and nectin-4 are the
known cellular receptors for MV. CD46 is a complement regulatory molecule which is expressed
on all nucleated cells in human beings. Activated T and B lymphocytes and antigen presenting
cells express the SLAM receptor. SLAM is favored by the wildtype MV strains. CD46 receptors
are favored by vaccine strains, although both wildtype and vaccine strains are capable of using
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either receptor to varying levels of efficiency (Navaratnarajah et al. , 2009). There are other
putative MV receptors called CD147/EMMPRIN (extracellular matrix metalloproteinase inducer)
on epithelial cells (Moss and Griffin, 2012). C-type lecithin DC-specific intercellular adhesion
molecule 3-grabbing non-integrin (DC-SIGN) plays a role in MV infection of dendritic cells (DC).
It appears to act as attachment receptor for DC. The epithelial cell receptor, Nectin-4, is a recently
identified receptor for MV (Noyce and Richardson, 2012). This receptor binds to proteins involved
in viral attachment with high affinity. MV entry and non-cytopathic spread in primary epithelial
cells is through Nectin-4 (Muhlebach et al. , 2011).

Several studies have tracked the movement of the virus through infected animals. Rhesus
macaques were infected with a strain of MV encoding genes for enhanced green fluorescent
proteins (EGFP). Examination of organs in MV-EGFP infected macaques revealed that lymphoid
tissues were the primary sites of replication (de Vries et al. , 2010, Lemon et al. , 2011). Viral
replication was seen primarily in T-cells, B-cells, and DCs first followed by replication in
epithelial cells during the later stages of infection. Similar studies were performed using hSLAM
transgenic mice, which were infected intranasally with wild-type MV expressing GFP. In this
study, they observed MV replication in alveolar macrophages and dendritic cells in lungs prior to
spread to lymphatic organs (Ferreira et al. , 2010). Lung epithelial cells were not infected. After
the initial replication, the virus migrates to other organs such as skin, kidneys, gastrointestinal tract
and liver. The virus also replicates in epithelial cells, endothelial cells, lymphocytes, monocytes
and macrophages. In the upper respiratory tract, lymphocytes are not present in large numbers but
DCs are abundant. DCs express CD150 and DC-SIGN and are found at the site of infection (de
Vries et al. , 2012). DCs are the predominant antigen presenting cells (APC) to the T cells, acting
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as a bridge between the innate and the adaptive immune system. Studies in vitro indicate that
infection of DCs with MV leads to syncytia and infectious virus formation. Both interstitial DC
(iDC) and myeloid DC are infected with MV and more than 40-90% of infected cell express MV
H envelope glycoprotein (Fugier-Vivier et al. , 1997, Grosjean et al. , 1997, Murabayashi et al. ,
2002). Thus, infected DCs lead to a highly productive infection. The host lymph node acts as a
factory for virus production after escaping the respiratory tract. From the lymph nodes, MV causes
a systemic infection.

Infection of wildtype MV in mice expressing human SLAM on DCs led to downregulation
of CD80, CD86, CD40 and MHC class 1 and 2. Thus, allogeneic T-cell stimulation and the
mitogen-dependent T-cell proliferation is inhibited. At the later stages of infection, an increase in
IFN-β transcripts was observed in MV-infected iDCs (Hahm et al. , 2004). The expression of the
co-stimulatory molecule may be reduced in mDCs in the secondary lymphoid organs. Therefore,
DCs attain a poor functional maturation status. MV-infected mDCs also produce IFNs, which
ultimately increases expression of maturation markers. Infected DCs lead to aberrant T-cell
function leading to reduced IFNγ production and inhibition of a Th1 response (Duhen et al. , 2010,
Shingai et al. , 2007).

1.7 Viral Replication
MV encodes for eight proteins including replication factors such as RNA-dependent RNA
polymerase (L) and phosphoprotein (P) and structural proteins such as nucleoprotein (N), matrix
(M), hemagglutinin (H), fusion (F), V, and C protein (Figure 5). The viral H and F proteins are
envelope glycoproteins that are critical for attachment and membrane fusion. MV-H attaches to
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the cellular receptor of the host cell providing a platform for MV-F to perform fusion activity.
(Rima and Duprex, 2009) The P gene encodes for three proteins: the P protein when the mRNA is
unedited and V and C proteins from alternate opening reading frames (Moss and Griffin, 2006).

After attachment of the virus to the host cell, the virus envelope fuses with the host plasma
membrane and viral RNA and proteins are released into the host cytoplasm. The viral genome is
complexed with N, P, and L which are the components of the viral ribonucleoprotein (RNP). This
complex is formed in the cytoplasm in infected cells. The RNA-dependent RNA polymerase
(RdRp) complex contains the L and P protein. It acts as viral transcriptase and replicase (Rima and
Duprex, 2009). For infectivity, every virion must contain a nucleocapsid/L/P complex. After the
cell fusion into the host, the negative strand RNA genome is inserted into the host cytoplasm where
it as acts as a template for both transcription and replication (Horikami and Moyer, 1991).

Transcription uses a negative-strand RNP complex to generate positive-strand mRNAs,
but during replication there is a switch from negative-strand RNP to positive-strand RNP by
RdRp, using its replicase function (de Swart, Ludlow, 2007). Viral proteins bind to the original
negative strand RNA to stop the signals of polymerase from stopping and restarting. Therefore,
full length positive strand can be generated which can be copied to create new negative strand
RNA viral genomes. The presence of a strong promoter at the 3’end of positive-strand RNP
allows several copies of RNP to be produced. Due to such replication mechanism, there exist
both positive-strand RNP and negative-strand RNP at the ratio of 0.43:1 in the infected cell
(Rima and Duprex, 2009). MV does not have any global effects on host protein translation. MV
tends to establish noncytolytic and persistent infections that leads to balanced synthesis of viral
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and host mRNAs and translation. The new virions bud from the host cells and acquires H and F
from the plasma membrane. This is the classical mechanism of virus spread to the neighboring
cells (Figure 5).
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Figure 5
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Figure 5. Measles virion and replication
A. Envelope proteins (H and F) are anchored on the lipid envelope of the virion. N, L and P
form the RNP complex, which is the basic unit of infectivity. B. MV genome consists of 16,000
nucleotides. The genome codes for 8 protein: V, C, P, N, M, F, H, and L. V and C are nonstructural proteins encoding P. C. MV enters the host through H and F by binding and attaching
to the host cell membrane. After entry transcription, translation and viral replication occurs.
The newly synthesized viral particle buds out of the cell and infects the neighboring cell to start
this process again. Therefore, it was proposed that there are “two initiation site one at 3’ end
that helps in synthesis of positive strand replicative RNA and the other one at the start of N
gene for mRNA synthesis (Horikami and Moyer, 1991). Thus, six short positive RNA strands
are generated and translated by the ribosomes to generate MV proteins. Along with RNP, there
are host proteins, actin and tubulin,
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that play a vital role in transcription. There are gene end sequences after every gene that
helps the transcription process to terminate. RNP follow follows this particular start and stop
mechanism of gene transcription that can give rise to a gradient of gene expression. Due to
this mechanism, the proximal genes (N and P/V/C) are expressed more repeatedly as that of
distal genes that is H and L. (Coughlin, Bellini, 2013) (Used with permission (Moss WJ,
Griffin DE. 2006. Global measles elimination. Nature reviews. Microbiology 4:900-908))
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1.8 Evasion of host response
As MV does not possess a segmented RNA genome, it is unable to undergo antigenic shifts in
an animal or bird reservoir to generate new sequences. MV also does not mutate extensively to
avoid neutralizing antibodies. The MV-F protein helps in viral entry by sticking the viral
envelope to the external membrane of target cells. This leads to formation of a giant cell with
multiple nuclei to be formed allowing MV to spread internally from cell to cell. Cytotoxic Tcells (CD8 T-cells) play a critical role in eliminating the infected giant cells. MV evades the
host defenses temporarily by causing transient immunosuppression of the host. Infection with
MV confers lifelong immunity after an immune response (Reviewed in (Mina et al. , 2015)).
Thus, susceptibility to opportunistic infections of respiratory and gastrointestinal tract is
increased. The common characteristics of immunosuppression includes lymphopenia and
imbalance of cytokines towards a prolonged Th2 response, which reduces cellular immunity to
secondary infections and T-cell non-responsiveness. Lymphopenia affects B-cells, monocytes,
neutrophils, CD4+ and CD8+ T-cells (Malvoisin and Wild, 1993). There also is a loss of
delayed hypersensitivity response to recall antigens, suggesting that memory immune responses
may also be impaired. (Tamashiro et al. 1987).

Several mechanisms have been postulated to explain immunosuppression. MV infected
DCs cause an upregulation of various cytokines, IL-1β, IL-6, IL-11, IL-12 and IL-15 (Griffin,
2010). The reduction of IL-12 is one of the proposed mechanisms of immunosuppression.
However, when monkeys were vaccinated with IL-12-expressing virus, it did not change the
lymphoproliferative effects of PBMCs ex vivo. This suggested that IL-12 alone cannot
compensate for the reduced proliferation of lymphocytes and other mechanism seem be
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essential. There may be compromised expression of chemokine receptor CCR7 in MV-infected
DCs. CCR7 is upregulated in mDCs, which allows cells to home to secondary lymphoid organs.
In vivo studies indicate a lower expression of CCR7 in PBMCs in infected children, which
might lead to impaired CCR7-dependent chemotaxis. Thus, further studies are required to
understand the role of CCR7 expression in chemotaxis of DCs during MV infection.

MV-infected DCs abrogate the expansion of T-cells. Functions of DCs such as T-cell
conjugation and activation are impaired post MV-infection. Vaccine and wildtype MV-infected
DCs are unable to stimulate T-cells in in vitro co-culture. The crosstalk between MV-infected
DCs and T-cells is compromised, which leads to insufficient T-cell stimulation. Griffin and
colleagues have shown that there is a reduction in interleukin-12 (IL-12) after MV infection of
APCs, which skews the CD4+ T-cell response to a Th2 profile. Several mechanisms other than
loss of mature lymphocytes have been proposed. The hematopoietic stem cells (HSC) that
express SLAM remains unaffected by infection, but unknown components are released from
infected stroma cells that target HSC differentiation. Thymocytes expressing CD150 may be
depleted during infection. Thymic epithelial cells may release chemicals that may induce
apoptosis. Thus, when T cells enter secondary lymphatic tissues, they are activated normally
but might behave differently in the periphery.

1.9 Measles in the central nervous system
MV replicates in the lymphoid tissue and spreads to the other organs. CNS invasion
may occur through the blood stream, transmigration of infected leukocytes across the blood
brain barrier, migration through the choroid plexus or infection of microvascular endothelial

33

cells and basolateral release of virus. Infected nerves of the olfactory bulb also can transport
the virus to the CNS (Reviewed in (Griffin, 2010)). Regardless of the mechanism of CNS entry,
MV routinely infects neurons in the CNS, and it may involve other neural cell types such as
oligodendrocytes and astrocytes. In neurons, MV assumes a distinct viral life cycle from the
periphery; the virus does not produce extracellular particles but moves between neurons through
transfer at the neuronal synapse. Thus, extracellular virus is not found in CSF or in brain tissue.
Makhortova et al have demonstrated the role of neurokinin-1 (NK-1) in transynaptic spread of
the virus by serving as a receptor for MV-F protein. But still, the molecular pathways involved
in viral entry neurons is not well understood. (Markhortova 2007).

1.9.1 CNS complications associated with MV infection

A. Subacute sclerosing panencephalitis (SSPE) is a progressive, slow, and fatal
disease that develops from 1 to 15 years after a MV infection (Dubois-Dalcq et al 1974). SSPE
occurs in approximately 1/100,000 cases of acute measles infection and clinical symptoms
appear months to years after the primary infection. The disease is characterized by progressive
dementia, starting with subtle cognitive loss early on and progressing to cognitive dysfunction,
motor loss, seizures, organ failure and death. Human SSPE specimens and MV animal models
show MV infection in the neurons and involvement of gray and white matter. SSPE brains show
the presence of cellular inclusion bodies, inflammation, glial activation, blood brain barrier
(BBB) integrity loss and neuronal loss. (Johnson 1994, Rall 2003). SSPE patients have elevated
MV-specific antibodies in the blood and cerebrospinal fluid (Dubois-Dalcq et al). MV does not
bud from the infected neurons either in vivo or in vitro. Unlike fibroblasts and epithelial cells,
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there is no formation of syncytia in MV-infected primary neurons. It is suggested that the viral
spread is contact-dependent and trans-synaptic in nature. Infected brains show extensive
presence of MV RNA and protein in SSPE and measles inclusion body encephalitis (MIBE)
(Katz 1995; Payne et al 1969).

Molecular epidemiological studies reveal that primary MV infection of patients with
SSPE occurs under the age of two, although the symptoms of SSPE may not occur until years
later. The immune response is immature during the neonatal period and the residual maternal
antibodies may either be absent or insufficient to neutralize the virus. SPPE is characterized by
intrathecal synthesis of MV-specific antibodies, which suggests that an antibody response is
ultimately mounted in the brain even if the antibodies are ineffective at controlling the virus.
There are also differences in MV replication and spread in the human CNS. The viral
transmission in the neuron is less cytopathic and productive compared to non-neuronal cells.
Studies in rat hippocampal slices found that the spread of rMV-EGFP occurs in a retrograde
direction with the MV F, H, M and P proteins localized to the dendrite in the infected neuron
(Ehrengruber, Ehler, 2002, Schneider-Schaulies et al. , 2003). Electron microscopy was used to
show the presence of MV nucleocapsids at the presynaptic membrane of infected primary
neurons. This suggested that the spread is in an anterograde direction or from the axon of the
infected neuron (Lawrence et al 2000).

B. Post-infectious encephalomyelitis (PIE) is more frequent than SSPE, affecting 1 in
1000 infected individuals. PIE symptoms occur 5 to 14 days after the characteristic MV rash.
(Johnson 1998). PIE and MIBE are is thought to be an autoimmune reaction characterized by
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perivascular inflammation and demyelination and does not involve viral entry into the CNS.
Symptoms of the PIE patients include seizures, deafness, ataxia, and movement disorders. The
mortality rate is high and survivors are prone to suffer from frequent neurologic symptoms.
Adults have a worse prognosis than young children (Schneider-Schaulies, Meulen, 2003) (Baba
et al. , 2006) (Perry and Halsey, 2004). PIE is not unique to MV, and can occur after other
bacterial and viral infections. This suggests PIE is not driven by specific damage by MV in the
brain but by an inappropriate immune response in CNS tissue.

C. Measles inclusion body encephalitis (MIBE)
This disease occurs in immunocompromised individuals within 1 year of MV infection or
vaccination. Young immunocompromised patients with conditions such as lymphoblastic
leukemia, HIV, and autoimmune diseases are affected by MIBE. The clinical symptoms
include seizures, partial epilepsy, and ataxia. These patients show the presence of MV specific
antibodies (IgM and IgG) in the cerebrospinal fluid (Mustafa et al. , 1993). Biopsies of MIBE
patient’s brains reveal neuronal loss, astrocytic, and microglial proliferation, focal necrosis,
perivascular inflammation, and intranuclear or intracytoplasmic inclusion bodies, which are
the pathological hallmark of the disease. There is no treatment for MIBE and it has a 76%
mortality rate (Fisher et al. , 2015, Mustafa, Weitman, 1993).

1.10 CD46+ Model
Genetically engineered mice are a powerful model to dissect the immune cell types and effector
functions that contribute to encephalitis or to successful resolution of the infection without
pathogenesis (Bergmann et al. , 2006, Brooks et al. , 2010, Burdeinick-Kerr et al. , 2009)
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(Manchester and Rall, 2001). Wildtype mice are not susceptible to MV because the murine
isoforms of the viral entry receptors (CD46, SLAM, nectin-4) do not support MV entry.
Transgenic mice have been engineered for MV susceptibility through the CNS neuron-specific
expression of the human isoform of CD46 (NSE-CD46), which acts as a receptor for the
Edmonston B strain of MV. Transgenic CD46+ mouse, which expresses the human isoform of
the measles virus receptor CD46 under the control of the neuron-specific enolase promoter
(NSE) (Rall et al. , 1997), is used as a model to study MV pathogenesis in the brain. In this
model, the human CD46 expression and viral infection are restricted to mature CNS neurons.
Previous studies observed that CD46+ adult mice control and clear MV in a T-cell and IFNγdependent manner. There is no evidence of loss of neurons or damage, suggesting a noncytolytic mechanism of viral clearance. CD46+ adults show no signs or symptoms of illness
and show viral clearance by 15 days post infection (dpi). However the neonatal CD46+ mice
succumb to the infection with severe neurological signs (Patterson, Lawrence, 2002)
(O'Donnell et al. , 2012). The mechanisms behind this failure of the neonatal immune response
in the brain are unknown.

In the current study, our goal was to understand the shortcomings of the neonatal
immune response in the brain and study the neuropathology post infection. Specifically, this
work will help to develop effective therapeutic strategies for viral infections in the neonatal
CNS, which are currently lacking, and provide a better understanding of neonatal susceptibility
to viral infections in the brain.
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CHAPTER 2
2. MATERIALS AND METHODS
2.1. Animals and ethics statement
Mice were maintained and treated in accordance with the Institutional Animal Care and
Use Committee of Duquesne University and the NIH Guide for the Care and Use of Laboratory
Animals. CD46+, CD46+/IFN knockout (KO), and CD46+/Recombination activating gene 2
(RAG-2) KO mice (A gift from Dr. Glenn Rall; Fox Chase Cancer Center, Philadelphia, PA)
were maintained on a 12:12 light/dark cycle under controlled temperature conditions
(20 ± 2 °C) with free access to food and water. Upon arrival, mice are acclimatized prior to use.
Breeding pair cages were established for the CD46+, CD46+/IFN KO and
CD46+/RAG2 KO mice in order to generate neonatal pups for infections. All mice at p21 were
sexed and equal numbers were used for adult experiments.

2.2 Genotyping CD46+ mice
In order to detect the CD46+ transgene, P21 mice were anesthetized, tail clipped, and numbered
by an ear punch at weaning. The tails were stored at -20C until extraction. DNA was extracted
from the tails using 1 mg of proteinase K (Fisher - BP-1700-50) in 500ul of Sodium ChlorideTris-EDTA (STE) buffer for each tail. The tails are kept overnight at 60C on a dry heat bath.
The DNA was extracted with 1X-Phenol:Chloroform:Isoamyl alcohol (25:24:1), vortexed at
high speed, and spun on high (13.2 RPM) in an Eppendorf centrifuge for 3 mins. The top
aqueous layer was removed and mixed with 500ul of chloroform: isoamyl alcohol. The
vortexing and spinning step is repeated. The aqueous layer was removed with a p200 pipette
tip and added into 1 ml of 100% ethanol. The DNA precipitates out and the centrifugation step
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is repeated. Then the DNA was air-dried after removing the ethanol for 10 mins. The pellet was
resuspended pelleted in sterile Tris-EDTA (TE) buffer and stored at 4C.

2.3 Measles virus infections
Mice were infected with Measles virus (MV)-Edmonston obtained from the ATCC
(American Type Culture Collection; Cat. No: VR-24). The virus was passaged twice in Vero
fibroblasts to create a passage 3 (P3) stock for infections. The vero cells were plated on a 6well plate. After 24 hours, the stock virus was diluted and different concentration of 10-1, 10-2,
10-3, 10-4 and 10-5 virus was added on the vero cells. The cells are incubated with the virus for
1 hour. 1% agarose was heated in a microwave and then placed in a 56 C waterbath. The DMEM
is placed in a 37 C water bath. After 1 hour, 1:1 ratio of DMEM and agarose are mixed. Each
well is overlayed with 4ml of the mixture.
Before infection, the inoculum was freshly diluted to 10,000 plaque forming units
(PFU)/10 µl with phosphate-buffered saline (PBS) prior to injection. On postnatal day 2 (P2),
pups were intracerebrally injected with virus, using a 27½ gauge needle, along the cerebral
midline. The uninfected control group was injected in the same location with an equal volume
of PBS (10 µl). Pups were monitored daily for symptoms of illness (seizures, tremors and
dehydration) and survival, up to 35 days post-infection. Mice were euthanized if seizures
developed. Adult mice (3-4 months of age) were anesthesized with isoflurane and injected with
30 µl (30,000 PFU) of MV along the cerebral midline. Infected mice were monitored for signs
of illness daily throughout the course of infection.
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2.4 Body weight and brain weight measurement
Both infected and control mice were weighed using digital balance and weights are
recorded in grams. The neonates were also assessed for measures of health and sickness. Edema
was recorded when observed at the later stages of infection.

2.5 Polymerase chain reaction (PCR)

To detect the CD46+ gene, PCR was performed using 10x PCR buffer, MgCL2, Taq
polymerase

(Fisher

FEREP0402 )

and

dNTP

(FERR0192),

CD46+

forward

(CGGTCGCTACCATTACCAGT) and reverse primer (CCCCCTGAACCTGAAACATA). The
PCR mixture along with 1ul of DNA was run on the thermocycler in RNAase free PCR tubes.
The primers are diluted in TE buffer and aliquots are stored at -20 C. For each PCR mixture the
following volumes were used.

Reagent

Volume

10x PCR buffer (KCL)

5 uL

25mM Magnesium chloride

3 ul

40mM dNTP mix

1 ul

Taq polymerase

0.5 ul

CD46+ forward primer (10 uM)

5 ul

CD46+ reverse primer (10 uM)

5 ul

Nuclease free water

29.5 ul

DNA template

1 ul

Total

50ul Final
volume/sample
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For each PCR, both a positive control (CD46+ tail) and a negative control (PCR mixture without
DNA) are run on the thermocycler. The thermocycler is set to (94 C 5 mins, 52 C 1min, 72 C
1min) x 25 cycles, 72 C for 5 mins. The CD46+ gene is a 250bp

DNA Electrophoresis
A 1.5% agarose gel was made in Tris/Borate/EDTA (TBE) buffer. The gel was poured in the
electrophoresis apparatus and allowed to solidfy. The 10ul of PCR product was diluted with 6X
DNA Loading dye. The samples were loaded on the gel and run at 50V for 2 hours. The gel
was then incubated with SYBR™ Green I Nucleic Acid Gel Stain, 10,000X
concentrate in DMSO (S7585, Thermofisher) for 1 hrs at 20C and imaged in the UV box
(Red Personal Gel Imager, Proteinsimple). The figure for the imaged gel is in (Figure 6). For
each run, both a tail from a CD46+ mice - positive control (+) and negative control were run
along with Generuler 100bp ladder (SM0241). The CD46+ product is 200bp (Figure 6).
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Figure 6.

Figure 6. DNA electrophoresis gel imaged by UV box.

A 1.5% agarose gel was run with tail DNA samples from CD46+ mice. The first column is the
100bp generuler ladder, followed by the positive and negative control. The adjacent wells
include the PCR product from RAG2-KO tails to confirm the presence of CD46+ in those
animals (For example 1M-D, 2M-D).
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2.6 Quantitative Reverse transcription polymerase chain reaction (qRT-PCR)
Quantitative RT-PCR for measles virus nucleocapsid (N) was performed as described
previously (O'Donnell, Conway, 2012). Mouse brains were snap frozen in liquid nitrogen and
stored at -80°C. RNA was isolated by TRIzol, according to the manufacturer’s instructions
(Sigma-Aldrich). Contaminating DNA was removed from RNA preparations using DNase I
treatment (Invitrogen). Purified RNA was quantified using a Nanodrop instrument. RNA was
reverse transcribed using Moloney murine leukemia virus reverse transcriptase (Ambion) and
a mixture of anchored oligo-dT and random decamers. For each sample, two reverse
transcriptase reactions were performed with inputs of 100 and 20 ng. An aliquot of the cDNA
was used for 59-nuclease assays using TaqMan chemistry. A TaqMan set speciﬁc for the N
gene of MV (GenBank sequence AB046218) was used for detecting viral nucleocapsid RNA.
Sequences were as follows: forward, 59-CGCAGGACAGTCGAAGGTC-39; reverse, 59TTCCGAGATTCCTGCCATG- 39; probe, 59-6Fam-TGACGCCCTGCTTAGGCTGCAABHQ1-39. Assays were used in combination with Universal Master mix and run on a 7900 HT
sequence detection system (Applied Biosystems). Cycling conditions were 95°C, 15 min,
followed by 40 (twostep) cycles (95°C, 15 s; 60°C, 60 s). The assay for MV-N was validated
with a 4-fold five-points dilution curve of cDNA. The slope was 23.54, corresponding to a PCR
efficiency of 95%. For each sample, the values are averaged and SD of data are derived from
two independent PCRs. Relative quantification to the control was done using the comparative
cycle threshold method.

For qRT-PCR analysis of the pathogen recognition receptors and interferons, we reverse
transcribed 1ug of RNA using QuantiTect Reverse Transcription Kit (20531, Qiagen) to
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produce cDNA, then amplified using primers from Integrated DNA Technologies (Coralville,
IA). We determined whether MV altered the mRNA expression of TLR3, TLR7, MDA5, RIGI,
Type I and Type II IFN and CIITA relative to Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). GAPDH is a loading control. The sense and antisense primer sequences are listed
(Table 1) (McCarthy et al. , 2015, Zalinger, Elliott, 2015). Real time PCR was performed using
Bullseye EvaGreen qPCR Mastermix (MIDSCI) on an StepOne Plus qPCR detection system
(Thermo Fisher Scientific) using a MicroAmp Fast optical reaction plate (4346906, Applied
Biosystems). mRNA was quantified as ΔCT (threshold cycle) values relative to GAPDH. ΔCT
values of the infected samples were expressed as fold changes over ΔCT values of control
samples. All statistical tests were performed using SPSS software. Significance of the F statistic
was defined as p≤0.05. The sense and antisense primer sequences are listed below (McCarthy,
Procario, 2015, Zalinger, Elliott, 2015).

2.7. Cytokine and chemokine gene expression (PCR array)
RNA was isolated from adult and neonate mouse brains using the Qiagen RNeasy Midi
Kit (75124, Qiagen, Valencia, CA) as per the manufacturers information. The brains were
homogenised in a Qiazol lysis buffer. The extracted RNA was assessed by UV
spectrophotometry to measure concentration and purity on a Nanodrop (ND-1000, Thermo
Scientific). Cytokine and chemokine gene expression was assessed using the mouse cytokine
and chemokine RT2 Profiler PCR Arrays (PAMM-150Z, Qiagen) by the manufacturer. The
expression of 84 inflammatory genes and 5 housekeeping genes were assessed. Data analysis
was done using the SABiosciences RT2 Profiler Web-Based PCR Array Data Analysis software,
which automatically performs the Delta Ct (ΔΔCt) fold-change calculations from the uploaded
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raw threshold cycle data. The fold changes were calculated after normalizing to their
housekeeping genes. This is followed by normalising all groups to uninfected CD46+ p9 control
when adults are compared to neonates and when neonatal comparisons are made. For the
baseline differences, all the genes were normalised to CD46+ p9 uninfected controls (Table 3
and Table 4). For each condition, infected neonatal brains (n = 16) and for uninfected n = 8
were used for the PCR array.
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Table 2 - Primer sequences
Gene

Abbreviation

Sequence

Measles

MV-F

CGCAGGACAGTCGAAGGTC

MV-R

TTCCGAGATTCCTGCCATG-

CIITA-F

GGAGGAGATCGAACTCAGCTC

CIITA-R

GTTCCGCAATGTTGGCATAGG

GAPDH- f

ACCACAGTCCATGCCATCAC

GAPDH- r

TCCACCACCCTGTTCTGTA

mIFN-a4-F3

CCCACAGCCCAGAGAGTGACC

mIFN-a4-R3

GGCCCTCTTGTTCCCGAGGT

mIFN-B-F4

TCCGCCCTGTAGGTGAGGTTGAT

mIFN-B-R4

GTTCCTGCTGTGCTTCTCCACCA

IFNG-F

AAAGAGATAATCTGGCTCTGC

IFNG-R

GCTCTGAGACAATGAACGCT

MDA5-F

GCTGCTAAAGACGGAAATCG

MDA5-R

CTTGTCGCTGTCATTGAGGA

RIGI-F

GCGTCTCAGTGCAGCACATCATT

RIGI-R

GGGTCCCGTGACTCTCCAAGTTT

TLR3-F

AGCTTTGCTGGGAACTTTCA

TLR3-R

GAAAGATCG AGCTGGGTGAG

TLR7-F

CCACAGGCTCACCCATACTT

TLR7-R

CAAGGCATGTCCTAG GTGGT

CIITA

GAPDH

IFNα

IFNβ

IFNγ

MDA5

RIGI

TLR3

TLR7
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2.8. Flow cytometric analysis of brain homogenates
At specific days post-infection (dpi), mice were deeply anesthetized with isoflurane.
Once the mice were unresponsive, the brain and spleen were removed and pressed through a 70
micron nylon mesh cell strainer in PBS. The dissociated tissue was run over a 30/70%
discontinuous percoll gradient at 1500 rpm for 20 min at 4°C (Eppendorf 5810 R). Mononuclear
cells were collected from the interface, washed with PBS, treated with 0.84% ammonium
chloride to remove contaminating red blood cells (RBCs), and washed again in PBS. Primary
antibodies (Abs) were applied in a solution of 1% fetal bovine serum/PBS for multi-color flow
cytometry. The following Abs (BD Biosciences) were used to identify T cells: APC CD8a
(561093), FITC CD19 (557398), PE CD4 (553048), PerCP-CYTM 5.5 CD3 Molecular complex
(560527). To identify NK cells, APC NK1.1 (55067), PE CD49b (553858), PerCP-CYTM 5.5
CD3 Molecular complex (560527) and FITC CD19 (557398) were used. All antibodies were
added at a concentration of 600ng/ml.

To identify neutrophils and inflammatory monocytes, PerCP CD45 (557235), CD11b
APC (eBioscience 17-0112-81) and Ly6G FITC (551460) were used at 1:50 dilution.
Infiltrating neutrophils were identified as CD45(hi)CD11b(+)Ly-6G(+) and F4/80-.
Inflammatory monocyte are classified as CD45(hi)CD11b(+)Ly-6G(-) F4/80+. Cells were
incubated with Ab for 1h at 4°C and then washed with 1% FBS/PBS, pelleted, stained cells
were resuspended and analyzed in a BD Accuri CFlow flow cytometer (BD Biosciences). For
each sample, 1x10^5 events were run, with gates to exclude debris and doublet cells. Single
antibody stains were used for color compensation and isotype controls were used for gating
(O'Donnell, Conway, 2012).
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Table 3A. Antibodies for T-cell and B-cell flow cytometry
T-cell panel
Catalog number

Antibody

Concentration

BD 560527

PerCP-CYTM 5.5 CD3 Molecular complex

600ng/150ul

BD 561093

APC CD8a

600ng/150ul

BD 557398

FITC CD19

600ng/150ul

BD 553048

PE CD4

600ng/150ul

Table 3B. Antibodies for NK cell flow cytometry
NK cell panel
Catalog number

Antibody

Concentration

BD 560527

PerCP-CYTM 5.5 CD3 Molecular complex

600ng/150ul

BD 55067

APC NK1.1

600ng/150ul

BD 553858

PE CD49b

600ng/150ul

BD 553048

PE CD4

600ng/150ul

Table 3C. Antibodies for neutrophil flow cytometry
Neutrophil panel
Catalog number

Antibody

Concentration

eBioscience 557235

PerCP CD45

1:50

eBioscience 17-0112-81

CD11b APC

1:50

eBioscience 551460

Ly6G FITC

1:50

eBioscience 553048

F4/80

1:50
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2.9. Immunohistochemistry of mouse brain tissue
Neonates and adult mice were anesthetized and perfused with ice-cold 4%
Paraformaldehyde/PBS (PFA/PBS). Brains from MV-infected and mock-infected neonates and
adults were collected and cut along the midline into two halves. The brains were post-fixed
with 4% PFA/PBS for 48 hours and cryoprotected with 30% sucrose solution till the brains sank
to the bottom of the tube at 4°C. Then the brains were immersed in tissue embedding compound
(TFM-5, TBS), frozen in a dry ice-isopentane bath, and stored at -80°C. Sagittal cryosections
(16 µM) were cut on a cryostat (Microm HM-550, GMI). Sections were post fixed with 4%
PFA/PFA and blocked with 5% goat and donkey serum. Standard immunohistochemistry was
performed to detect mouse anti-measles hemagglutinin (Millipore MAB8905; 1:200), mouse
measles matrix protein (Millipore MAB8910; 1:200), and rabbit anti-ionized calcium-binding
adapter molecule 1 (Iba1) (Wako 019-19741; 2µg/ml) for microglia overnight at 4°C with
combination of primary antibodies. Sections were washed (3x in PBS) and incubated with
Alexa fluor 488 donkey anti rabbit IgG (Molecular Probes A21206; 1:500), Alexa fluor 555
goat anti-mouse IgG (Molecular Probes A21424; 1:500) secondary antibodies, and Hoechst
33343 stain (Thermofisher; 1 g/ml) for 1 hour at room temperature in the dark.
Immunoreaction controls were carried by omission of primary antibodies. Sections were
imaged using an EVOS epifluorescence microscope at 200x magnification. No primary
antibody and isotype controls were performed. For all the histological analyses, at least five
sections per brain were examined and at least four mice per experimental group were assessed.
The stich images were captured using Olympus epifluorescence.
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3. TUNEL staining
Brains from control and MV-infected mice were collected after perfusion. Sagittal brain
sections were fixed with 3.7 % formaldehyde and subjected to terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL; (TdT-FragEL DNA fragmentation detection kit;
Millipore) using diaminobenzidine as a substrate. For counting of TUNEL-positive cells, four
non-overlapping fields (×20) were chosen by a blinded examiner moving dorsally to ventrally
across the slice. TUNEL-positive cells were counted on an Olympus BX41 Laboratory
Microscope (Olympus Corporation). Three sagittal slices were counted from each brain, with
three mice assayed per condition. The average number of TUNEL-positive cells per ×20
field ± standard error was determined.

3.1 IFNα ELISA
Whole brains were lysed in RIPA buffer with 500ul of PMSF, 1% protease inhibitor cocktail
and 10% NP-40. After sonication, the samples were centrifuges at 27,000g for 20 mins and
stored at -20 C. The protein concentration was determined by Pierce BCA Protein Assay Kit
(Life Technologies). The standards provided in the IFNα kit (PBL lifesciences) were run. The
brain homogenates (150ug of protein) and standards were diluted with 1% casein/sample buffer.

3.2 Intracellular IFNγ staining/ T cell culture.
Spleens from 5 MV-infected and uninfected CD46+ adults were isolated and mechanically
dissociated with plunger and forceps. The petri dish was rinsed and the homogenate was
transferred to a conical flask. Percoll discontinuous gradient was used to isolate the
lymphocytes. The cells from the interphase were resuspended in 50ml of RPMI media and
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Interleukin 2. The cells were then plated in a T-75 flask and allowed to settle in the incubator
for 1 hr. The cells were viewed under the microscope to check if they had settled. Once the cell
attached, the media containing the floating T-cells were removed and transferred to a new T75. The cells were then incubated until the APC counts were finished.

T-cells and APCs were counted and plated in the following ratios: 1:4, 1:10, 1:25, and
1:50. The experimental groups that were included in the analysis were: 1. Uninfected APC:
Uninfected T-cells and 2. Infected APC: Ionomycin + infected T-cells. After incubation, sterile
PBS w/o Ca+2/Mg+2 was added followed by 2.5% trypsin. The trypsin was incubated at 37 C in
the incubator for five minutes. Once the cells started to float, RPMI media was added and the
cells were then resuspended. Macrophages/APCs were plated separately. The cells were spun
at 1500rpm at or 23 C for 5 mins at a high brake. The cells were resuspended in a smaller
volume of 100ul for T-cells. In a 96 well plate, 2 x 106 Tcells/well were plated in a 96 well
plate for both infected and uninfected group. 10U/ml of IL-2 was added to each well.
Brefeldin A and Golgi Stop (Monesin) (2ul/well Brefeldin and 1.3ul/well Golgi Stop)
were added to each well. After 3 hours, the cells were washed and resuspended in FACS buffer.
A mixture of CD3, CD4 and CD8 Ab were made in FACS buffer. The cells were incubated in
the dark for 1 hr and washed and resuspended. The cells were then run on the flow cytometer
as for T cell flow cytometry.

3.3 Western Blot
Neonatal brain tissue was harvested at 3, 7 and 10 days post-infection (dpi) for western blot
analysis. Mice were perfused with 10mM NaF in ice-cold PBS in order to inhibit endogenous
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phosphatases. The brains were dissected for the cerebellum, hippocampus, neocortex, and
thalamus and lysed in cell Lysis Buffer with Protease inhibitors (Cell Signaling; 20 μl/mg of
tissue). The lysate was stored at -80°C until further use. The protein concentration of each
lysate was measured using Pierce BCA Protein Assay Kit (Life Technologies). For each sample
harvested, 20 μg of lysate was subjected to western blot analysis. The membranes were treated
with primary antibody solutions overnight at 4°C on a rocker. The primary antibodies used
included goat anti-mouse CXCL10 (1ug/ml; RAF466NA, R&D Systems) and mouse antimouse interferon gamma (1:100, Santa Cruz Biotechnology). The membranes were washed
thrice and incubated in secondary antibody solutions for 60 mins at room temperature. The
membranes were imaged on the Odyssey infrared imaging system (Licor Biosciences).
Individual bands on blots were quantified by Image Studio. Multiple antibodies IFNα
(ab191903, Abcam) and IFNβ (sc-17569, Santacruz; NBP177288E, Novus; ab85803, Abcam)
was used, but these resulted in non-specific bands (data not shown)

3.4. Statistical Analysis

Statistical analysis for the Kaplan-Meier plot was performed by log rank test to compare
survival across different genotypes. A two-way ANOVA was performed to compare body
weight, brain weight, viral load, NK cell infiltration, T-cell infiltration, neutrophil, and qRTPCR data with Bonferroni post hoc test (p<0.05 considered as significant). For the cytokine
array, p values were calculated based on a student’s t-test to compare the control and treatment
groups. Three-way ANOVA was done to compare the differences between the Type I IFN and
MDA5 gene expression (Figure 21). Differences were deemed significant when p values were
less than 0.05. Statistical analysis was performed using GraphPad Prism software 6 (GraphPad
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Software, Inc., La Jolla, CA) and SPSS. Outliers were identified using the Grubb’s method and
the alpha level was set to 0.05 using Graphpad Prism.

53

CHAPTER 3
Role of IFNγ-producing innate and adaptive immune cells during a neurotropic measles
virus infection

3.1

Hypothesis
Inadequate infiltration of IFNγ-producing immune cells in the CNS may contribute to

mortality and neuropathology in the CD46+ neonates.

3.2

Rationale
Neurotropic virus infections continue to impose major disease and economic burdens

on society. When these infections are in the neonates or children, they are associated with
neurological sequelae and higher morbidity and mortality worldwide (Das and Basu, 2011).
Additionally, there are qualitative and quantitative deficiencies in immune cells during the
neonatal period (Zaghouani, Hoeman, 2009). Therefore, there are great challenges in treating
these patients as age and immature host immunity are key factors. Moreover, the pathogenesis
of neurotropic viruses in the neonatal brains are not well understood.

Viral infections in non-replicating neurons lead to lasting neurological consequences, if
a cytolytic immune strategy is employed to clear or control the virus (O'Donnell, Conway,
2012). The severity of neurotropic virus pathogenicity may be dictated by the delicate balance
between achieving viral clearance and removing virally-infected cells: effective immunity must
control the infection while minimizing cytotoxic T lymphocyte (CTL)-mediated lysis of this
chiefly nonrenewable cell population. Interferon-gamma (IFNγ) is a potent anti-viral cytokine
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that is critical for non-cytolytic clearance of multiple neurotropic viral infections and clearance
of measles virus (MV) from the adult CNS. Thus, the role of IFNγ in the neonatal CNS is
explored in this study. It is known that the adult immune response can protect the mice from
disease, but neonates developed unrestricted neuronal infection and fatal CNS disease
(Lawrence et al. , 1999) (Patterson, Lawrence, 2002). Therefore, we explored whether neonates
can mount an immune response during a viral CNS infection. The goal of this project was to
understand the shortcomings of the neonatal immunity during a viral CNS infection.

The immune system has two main arms: a generic innate response followed by a
pathogen-specific adaptive response. The innate immune system cells constitute neutrophils,
antigen presenting cells (APCs) such as macrophages, and natural killer cells (NK cells). We
studied innate immune cells, such as NK cells, because they can produce pro-inflammatory
cytokines such as TNFα and IFNγ and various chemokines during an inflammatory response.
These innate cells also are capable of direct lysis of infected cells, recruitment of other nonspecific innate cells like neutrophils and macrophages, and modulation of T-cell and B-cell
responses (Ljunggren and Malmberg, 2007). Thus, if NK cell infiltration is low it may affect
several arms of the anti-viral immune response.

Adult CD46+/RAG2-KO mice, which lack adaptive immunity, show extensive MVmediated neuropathology and high mortality post infection. This suggests that innate immune
response is unable to mediate MV control in an adult CNS (Patterson, Lawrence, 2002).
However, the role of the innate and adaptive immune response in the neonatal CNS are not well
understood. For example, studies suggest that neonatal neutrophils have quantitative and
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qualitative defects (Melvan et al. , 2010). The neutrophil storage pools and neutrophil
progenitor production is reduced compared to adults. Neonatal neutrophils also show reduced
expression of TLR4 but similar levels of TLR2 compared to adults (Melvan, Bagby, 2010).
Additionally, there are defects in downstream signalling of MyD88 and p38 pathways (Figure
2) (Al-Hertani et al. , 2007). Thus, multiple lines of evidence suggest that the neonatal innate
immune response may demonstrate deficits or impairments in cellular responses and number.
To determine whether innate immunity in the brain is similarly impaired, we explored whether
the neonates are capable of mounting an innate post a neurotropic infection in the brain.

We used transgenic CD46+ mice to study neuron-restricted measles virus infection in
the brain. Immunocompetent CD46+ adult mice initiate a protective adaptive immune response
with infiltration of CD4 and CD8 T cells as early as 3 days post-infection (dpi), with peak T
cell infiltration between 7-14 dpi. MV infection is resolved typically by 30 dpi without any
symptoms or signs of illness and there is 100% survival (Patterson, Lawrence, 2002). Mice
without T and B cells (CD46+/RAG2-KO) and mice that lack (CD46+/IFN-KO) die with
rampant MV spread within a month after infection. Adult CD46+/IFN-KO mice do not clear
the virus, with ~50% of the mice succumbing to the infection within 21 dpi. The surviving
CD46+/IFNγ-KO mice showed long term neurological damage, including ataxia, piloerection,
and hunched posture. Therefore, both T cells and IFN are critical to the survival of adult
CD46+ mice (O'Donnell, Conway, 2012). Thus, we also wanted to define the role of IFNγ and
the adaptive immunity in MV-infected neonates.
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3.3

Results

3.3.1 IFN delays, but does not prevent, mortality in infected neonates
To study the outcome of infection in neonates, 2-day old CD46+ mice were infected
with MV and monitored for signs of illness and mortality (Figure 7). As a control for the
injection procedure, CD46+ neonates were injected with 10µl of PBS intracerebrally and did
not show signs of illness over the course of the experiment. MV-infected CD46+ neonates
succumbed to the virus by 16 dpi, with 50% mortality by 8 dpi. During the infection, MVinfected neonates showed signs of illness including dehydration, lethargy, and tremors starting
at 6 dpi, with seizure activity before death. Previous studies have shown that IFN-producing
T cells are required for MV clearance in adult CD46+ mice (Lawrence, Vaughn, 1999,
O'Donnell, Conway, 2012, Patterson, Lawrence, 2002). To determine if IFN contributed to
the outcome of infection in neonates, CD46+/IFN-KO pups were infected with MV and
observed for signs of illness (Figure 7, closed circles). MV-infected CD46+/IFN-KO pups
succumb to the infection earlier than CD46+ pups, reaching 100% mortality by 10 dpi. We also
investigated the role of the adaptive immune system in neonates using recombinase activating
gene 2 knockout (CD46+/RAG2-KO) mice that lack mature T and B cells (Figure 7, open
diamonds).

Surprisingly, CD46+/RAG2-KO neonates survive longer than CD46+ and

CD46+/IFN-KO neonates. At 35 dpi, 20% of CD46+/RAG2-KO neonates had survived the
infection with less signs of illness than the other CD46+ genotypes. These observations suggest
that the adaptive immune response may play a detrimental role during neonatal infection, in
contrast to the protective role that it plays in the adult brain. These findings also demonstrate
that IFN delays the outcome of infection but is insufficient to protect the CD46+ neonates from
death.
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3.3.2 Measles virus RNA is lower in the absence of IFN compared to CD46+ neonates
As CD46+/IFN-KO neonates succumb to the infection earlier than CD46+ neonates;
one possibility is that MV replication is greater in the absence of IFN, thereby leading to
more rapid death. To determine if survival correlates with the viral load in the brain,
expression of measles virus nucleocapsid (N) RNA was determined in brain tissue using qRTPCR (Figure 8). We focused on 4 and 6 days post-infection, as these time points correspond
with early T cell infiltration (4 dpi) and with more extensive T cell infiltration (6 dpi).
Regardless of immune background, MV RNA increased in all neonates over time, although
this increase was only significant in CD46+ pups (p<0.001). Unexpectedly, CD46+ neonates
had a higher viral load compared to CD46+/IFN-KO (p<0.05) and CD46+/RAG2-KO
neonates at 6 dpi (p<0.001, Figure 8A). Thus, the level of viral RNA did not correlate with
survival in the CD46+ neonates (Figure 7). This result suggests that the virus may not be
directly causing death in neonates, but rather the nature of the host immune response may be a
better predictor of survival. Regardless of genotype, levels of MV N-transcripts were higher
in neonates than in adults (Figure 8B), which may reflect both a more successful anti-viral
response in adults and/or the ability of the virus to readily spread in young neurons.
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Figure 7.

Figure 7. IFN delays, but does not prevent, mortality in infected CD46+ neonates.
Kaplan-Meier plot of CD46+ neonates on various knockout backgrounds. CD46+,
CD46+/INF-KO, and CD46+/RAG2-KO neonates were infected intracranially with measles
virus (MV) (10^4 PFU/10μl PBS) at 2 days of age. Mice were monitored for symptoms of
illness and death for 35 days post-infection. Statistical analysis was applied by log rank test
(p < 0.0001). Results from 4-6 separate litters were pooled (n = 30-50 mice per condition).
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Figure 8.
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Figure 8. CD46+ neonates have the highest viral load compared to CD46+/INF-KO and
CD46+/RAG2-KO neonates. Whole brains from neonatal (B) and adult (C) MV-infected mice
were collected at 4 and 6 dpi. RNA levels of measles virus nucleocapsid (N) transcript were
quantified using qRT-PCR. Bars represent the average of mice from three independent
experiments (n=9-14) and error bars represent SD. Statistical analysis was applied by twoway ANOVA (# p<0.001, * p<0.05, NS = not significant) with Bonferroni post hoc test.
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3.3.3 Impact of MV-infection on body and brain weights
MV-infected neonates showed clinical neurological symptoms such as ataxia and
seizures, as well as signs of weight loss and dehydration. From 7 dpi onwards, the clinical
symptoms increase followed by neonates succumbing to the infection. We also observed that
some CD46+/IFN-KO neonates (~8%) developed hydrocephaly, with relatively smaller brains
upon dissection. The enlarged head and skull was filled with fluid upon dissection, but the
actual brain was smaller (Figure 9). Thus, we wanted to determine if the loss of body weight
correlated with changes in brain weight during infection (Figure 10). At the initial stages of
infection (2 dpi), there is no difference in the body or brain weight of MV-infected CD46+
neonates (Figure 10A and 10C) or MV-infected CD46+/IFN-KO (Figure 10B and 10D)
compared to uninfected controls. As the infection progresses, CD46+ neonates lose body
weight at 4 dpi (11.7% loss compared to uninfected controls) followed by a transient increase
in body (13.5%) and brain weight (6.2%; p<0.05) at 6 dpi. MV-infected CD46+/IFN-KO
neonates also show an increase in brain weight at 6 dpi (13%), but there is no difference in body
weights compared to control. At 10 dpi, MV-infected CD46+ (loss of 10.3% brain weight, 21%
body weight) and CD46+/IFNγ-KO (loss of 14.3% brain weight, 29% body weight) neonates
show a significant decrease in brain and body weight compared to age-matched controls. Thus,
MV-infected pups showed limited growth at the end stages of infection (10 dpi), when
neurological symptoms are also the most severe. The finding that brain weights increased at 6
dpi, regardless of IFN expression, was surprising, as neurological symptoms are apparent at
this time point. However, one possibility is that the temporary increase in brain weight could
be due to edema or increased fluid retention in the tissue at that stage of infection, as the brains
were not dried to eliminate water weight before measurement. Regardless of the increase in
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weight at 6 dpi, the loss of brain and body weights occurred independently of IFN, even when
edema was not observed.
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Figure 9.

Control

CD46+/IFNγ-KO MV

Figure 9. Hydrocephaly is observed in MV-infected neonates in the absence of IFN.
CD46+/IFNγ-KO and CD46+ mice were infected with MV (1x10^4 PFU) at 2 days of age.
Mice were monitored for signs of illness. CD46+ neonates did not demonstrate overt
changes in head size during the infection. In ~8% of CD46+/IFNγ-KO neonates (Figure 8B),
enlarged heads and skulls were observed at the later stages post-infection.

Upon

dissection, edema was observed in the intracranial space, with fluid accumulation in the brain
and reduced brain size. CD46+/IFNγ-KO neonates 8dpi MV skull (Figure 8B) is compared to
age matched uninfected CD46+/IFNγ-KO neonate.
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Figure 10.
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Figure 10. CD46+ neonates lose body and brain weight at early and late time points
post-infection.
The brain weights (A, B) and body weights (C, D) of CD46+ (A, C) and CD46+/IFN-KO
neonates (B, D) at different time points post-infection were measured. Weights were
recorded at the time of harvest for flow cytometry experiments. Mean values are
represented by horizontal bars for each condition. Statistical analysis was applied by twoway ANOVA (* p<0.05) with Bonferroni post hoc test.
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3.3.4. IFN expression does not prevent apoptosis during infection.
Previous studies from our laboratory have demonstrated that IFN can be neuroprotective
against certain insults in vitro. Therefore, we wanted to test whether the CD46+/INF-KO
neonatal brains showed greater apoptosis post infection. Terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) staining was performed. We found that brain sections are
strongly positive in the TUNEL reaction, particularly in the cerebellum. There is a significant
increase in the number of TUNEL+ cells in both MV infected CD46+ and CD46+/IFNγ-KO
brain sections compared to their age-matched uninfected controls (Figure 11). However, there
is no significant difference between CD46+ and CD46+/INF-KO, indicating IFN may not
reduce the number of cells undergoing apoptosis in the neonatal brain.
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Figure 11.

Figure 11: IFN does not prevent apoptosis in neonatal brain tissue during infection.
Whole brains CD46+ control neonates (A) and CD46+ MV-infected neonates (B) were
collected at 7 dpi. Sagittal sections from the neocortex were immunostained for apoptotic
cell (brown) and healthy cells (green). Slides from 4-5 mice per condition were examined,
and representative sections with TUNEL+ cells are shown. The number of TUNEL+ cells is
counted from 3 fields per condition.
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3.3.5. Microglial activation occurs in the absence of IFN during infection
IFN stimulates the activation of microglia and induces expression of chemokine genes
that are mediators of T-cell recruitment (Rock et al. , 2005). Because microglia is highly
sensitive to IFN, we examined changes in microglial activation post MV-infection in the
neonatal brains. We hypothesized that pups lacking IFN would show limited microglial
activation during infection. Sagittal brain sections were immunostained for a marker for
activated macrophage/microglia (Iba1; green) and for measles virus antigen using antibodies
against the matrix and hemagglutinin protein (red, Figure 12). In CD46+ (Figure 12A),
CD46+/IFN-KO brains (Figure 12B), activated microglia were observed with bright Iba1
staining in the brain parenchyma in comparison to uninfected controls. MV antigen was
observed in the prefrontal cortex, thalamus, and cerebellum at 7 dpi regardless of IFN
expression. At later stages from 7 to 10dpi, there is widespread MV infection throughout the
CNS, including involvement of the hippocampus, which is also highly infected in adults (data
not shown). Activated microglia was consistently observed in close proximity to MV-infected
neurons. In brain regions with MV+ cells, Iba1+ cells showed ameboid morphology with
rounder cell bodies and retracted processes, which is indicative of activation during infection,
in both CD46+ and CD46+/IFN-KO pups. Iba1+ cells in uninfected brains show thin, ramified
processes and with less intense Iba1 staining (Figure 12A and 12B, top rows) in comparison
to MV-infected brains. Thus, microglial activation is observed in the absence of IFN,
suggesting that other cytokines/chemokines can trigger activation of microglia during infection.
We further looked at the distribution of infection in several brain regions such as hippocampus
and thalamus (Figure 13A). We also observed greater Iba1 expression in areas of the brain that
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also contained higher numbers of MV-infected neurons (Figure 13B). These results suggest
that neuronal infection leads to microglial activation in the surrounding brain tissues in neonates.

Figure 12.
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Figure 12. Microglial activation occurs during MV-infection in an IFN-independent
manner.
Whole brains from MV-infected and uninfected control CD46+ neonates (A) and
CD46+/IFN-KO neonates (B) were collected at 7 dpi. Sagittal sections from the neocortex
were immunostained for measles (Hemagglutinin and matrix; red) and microglia (Iba1;
green). Slides from 4-5 mice per condition were examined, and representative sections with
MV+ cells are shown.
Figure 13.
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C. CD46+/IFN-KO
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Figure 13. MV infection in the thalamas in both CD46+ and CD46+/IFN-KO neonates
Sagittal sections were immunostained for measles (Hemagglutinin and matrix; red), microglia
(Iba1; green) and Hoechst 33342 stain (blue) as a nuclear marker. CD46+ 7dpi MV infected
thalamus at 20x (A) and 40x (B). Stitched image of CD46+/IFN-KO brain at 7dpi MV (Scale
bar = 200µm) (C). Slides from 4-5 mice per condition were examined, and representative
sections with MV+ cells are shown.
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3.3.6. IFN does not affect natural killer cell infiltration
Natural killer (NK) cells play an important antiviral role by direct lysis of infected cells
and/or release of antiviral cytokines such as IFN, particularly during early stages of infection
before a specific adaptive response is mounted (Biron, Nguyen, 1999, Paolini et al. , 2015).
Since NK cells can be major producers of IFN, we investigated whether NK cells infiltrate
into the brain parenchyma in neonates. As NK cells are part of the innate immune response, we
quantified the early stages of infection (2 and 4 dpi) as well as a time point where T cell
infiltration was increasing (6 dpi) (Figure 14). At 2 and 4 dpi, there is no significant difference
in MV-infected pups compared to uninfected controls in both the genotypes. At 6 dpi, there is
a significant increase in total NK cell number (NK1.1+, CD49b+, and NK1.1+/CD49b+) in
MV-infected neonates compared to uninfected controls in both CD46+ (Figure 14A, p<0.05)
and CD46+/IFN-KO (Figure 14B, p<0.001) genotypes. Collectively, these data show that
NK cells arrive in the CNS during infection independently of IFN.
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Figure 14.
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Figure 14. Infiltration of NK cells into the CNS is independent of IFN.
Whole brain homogenates from CD46+ (A) and CD46+/IFN-KO (B) neonates were analyzed
for total natural killer (NK) cell numbers at 2, 4, and 6 dpi by flow cytometry (CD3/NK1.1+/CD49b+). The horizontal line represents the mean number of cells for each
condition. Results from 4-5 different litters were collected, and statistical analysis was applied
by two-way ANOVA (# p<0.001, * p<0.05) with Bonferroni post hoc test. Whole brain
homogenates from MV-infected CD46+, CD46+/IFN-KO, and CD46+/RAG2-KO neonates
(C) were analyzed for neutrophils numbers (CD45hi/CD11b+/Ly6G+) at 4 dpi and 6dpi by flow
cytometry. Results from 3 different litters were collected, and statistical analysis was applied
by one-way ANOVA (* p<0.05) with Bonferroni post hoc test.
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3.3.7

IFN limits neutrophil and inflammatory monocyte infiltration into the CNS
We next investigated whether IFN affects neutrophil infiltration in the CNS.

Neutrophils are recruited early in viral infections, and can contribute to tissue damage through
protease and oxidase release during viral clearance (Drescher and Bai, 2013). Activated
neutrophils produced ROS that activates innate immunity during HSV infection (GonzalezDosal et al. , 2011). Neutrophils were identified as a population with CD45(hi), CD11b+, Ly6G+ cell type (Mutnal et al. , 2010). CD11b is a marker found on several cells such as monocytes,
granulocytes, macrophage, and natural killer cells. The F4/80 Ag is expressed on tissue resident
macrophages such as microglia. Ly6G is exclusively expressed on neutrophils; hence helps
distinguish it from monocyte and macrophage population. Thus, a neutrophil is defined as
CD45hiCD11b+++F4/80- Ly6G+ cells are neutrophils (Howe et al. , 2012).

In neonates that lack IFN, neutrophil infiltration is significantly higher compared to
CD46+ neonates at 4 and 6 dpi (Figure 15A). CD46+/RAG2-KO neonates also show
progressively elevated levels of neutrophils in the CNS, but it is not significantly different from
CD46+ or CD46+/IFN-KO neonates at either time point. This suggests that IFN may
downregulate neutrophil recruitment in the CD46+ neonates during infection, and that
excessive neutrophil infiltration may correlate with earlier death in CD46+/IFN-KO neonates.

During brain insults, circulating monocytes migrate to the breached BBB and enter the
brain. Thus, both the infiltrating monocyte and microglia contribute to the neuroimmune
response in the brain (Mildner et al. , 2009, Prinz et al. , 2011). Gene expression profiles
indicate that infiltrating monocytes are highly inflammatory in experimental autoimmune
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encephalomyelitis (EAE) models compared to microglia. Inflammatory monocytes were
defined as cells expressing CD45hiCD11b++F4/80+Ly6G- markers by flow (Howe,
Lafrance-Corey, 2012). In neonates without IFN, inflammatory monocyte numbers are
highest at 6dpi compared to CD46+ and CD46+/RAG2-KO neonates (Figure 15B). From 4 to
6dpi, there is a significant influx of inflammatory monocyte in CD46+/IFN-KO neonates
post infection. In CD46+/RAG2-KO, there is an increase in infiltrating monocytes as the
infection progresses from 4 to 6dpi. This suggests that both neutrophils and monocytes
respond to the infection at 6dpi. In other CNS infection models, these cells were seen 12
hours post infection.
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Figure 15.
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Figure 15. Infiltration of neutrophils and inflammatory monocytes cells into the CNS is
independent of IFN.
Whole brain homogenates from CD46+ (A) and CD46+/IFN-KO (B) neonates were analyzed
for neutrophils cell numbers at 2 and 4 dpi by flow cytometry (CD45hi/CD11b+/Ly6G+/F4/80)
and inflammatory monocytes (CD45+/CD11b+/Ly6G-/F4/80+). The horizontal line represents
the mean number of cells for each condition. Results from 4-5 different litters were collected,
and statistical analysis was applied by two-way ANOVA (# p<0.001, * p<0.05) with
Bonferroni post hoc test.
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3.3.8 Higher infiltration of neonatal T cells in the absence of IFN at later stages of
infection
We observed the presence of NK cell, neutrophils, and inflammatory monocytes in an
IFNg independent manner in the neonatal CNS. We wanted to understand if CD4 and CD8+ Tcells, which are critical for MV control in the adults (O'Donnell, Conway, 2012) infiltrate into
the neonatal CNS. Using flow cytometry of whole brain homogenates, the numbers of CD4 and
CD8 T cells in the neonatal brain were quantified at 4, 7, and 10 dpi, which corresponds to time
points where T cells are first observed by immunohistochemistry (4 dpi) and time points that
parallel peak infiltration of T cells in adults (7 and 10 dpi). At 4 dpi, there is no difference in
the number of CD4 or CD8 T cells in the infected CD46+ neonates compared to uninfected
controls (Figure 16A and 16B). There is higher infiltration of CD4 T cells in the absence of
IFN early in infection at 4 dpi (Figure 16A). Similarly, at 7 dpi, significant CD4 T cell
infiltration was observed only in the absence of IFN (Figure 16C), whereas CD8 T cell
infiltration was induced in MV-infected neonates regardless of IFN expression (Figure 16D).
At later stages of infection (10 dpi), significant infiltration of CD4 (Figure 16E) and CD8 T
cells (Figure 16F) was observed only in the CD46+/IFN-KO pups in comparison to uninfected
controls. CD46+ pups did not show a significant increase in CD4 or CD8 T cells at 10 dpi,
although a trend toward increasing CD8 T cell number was observed (p=0.082). Comparing
across genotypes, CD46+/IFN-KO neonates have significantly higher infiltration of CD4 T
cells (p<0.001) and CD8 T cells (p<0.05) compared to CD46+ neonates at 10 dpi. Thus, these
results suggest that IFN may have a suppressive/anti-inflammatory effect on T-cell infiltration
at later time points in infection.
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We also monitored the changes in T-cells over time (Figure 17). In CD46+/IFN-KO
neonates, there is significant decrease in CD4+ T-cell influx from 4 to 7dpi. This is followed
by a significant influx of CD4+ T-cells from 4 to 10dpi and from 7 to 10dpi in CD46+/IFNKO neonates (Figure 17A). In CD46+ neonates, there is a slight increase in CD4+ and CD8+
T-cells over time but it is not significant (A and B). When compared across genotypes,
CD46+/IFN-KO neonates have higher infiltration of CD4+ T-cells at 4dpi and 10dpi compared
to age matched infected CD46+ neonates. Infiltration of CD8+ T-cells is the highest in
CD46+/IFN-KO compared to infected CD46+ neonates at 10dpi (Figure 17B). As the
infection progresses, CD46+/IFN-KO neonates show a significant influx of CD8+ T-cells from
4 to 10dpi and from 7 to 10dpi. This may be due to a breakdown of blood brain barrier in
CD46+/IFN-KO neonates at the later stages of infection. There is no change in CD8+ T-cell
infiltration during early stages of infection from 4 to 7dpi in CD46+/IFN-KO brains. In the
CD46+ neonatal CNS, there is increase in CD4 and CD8 T-cells as the infection progresses
from 7 to 10dpi. This may contribute to high viral load seen in the CD46+ neonatal brains
(Figure 8).
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Figure 16.
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Figure 17.
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Figure 16. Neonates show higher T cell infiltration at later stages of infection in the
absence of IFN.
Flow cytometry was performed on whole brain homogenates for CD4 T cells
(CD3+/CD4+/CD19-) or CD8 T cells (CD3+/CD8+/CD19-). CD4 T-cells (left column; A, C, E)
and CD8 T cells (right column; B, D, E) were quantified in uninfected and MV-infected CD46+
and CD46+/IFN-KO neonates at 4 (A, B), 7 (C, D), and 10 dpi (E, F). The black line
represents the mean number of cells for each group. Results represent pups from 4-5
different litters. Statistical analysis was applied by two-way ANOVA (* p<0.05, # p<0.001) with
Bonferroni post hoc test.

Figure 17. Higher infiltration of CD4 (4 and 10dpi) and CD8+ T-cells (10dpi) in the
absence of IFN at 10dpi. Flow cytometry was performed on whole brain homogenates for
CD4 T cells (CD3+/CD4+/CD19-) or CD8 T cells (CD3+/CD8+/CD19-). CD4 T-cells (A) and
CD8 T cells (B) were monitored as the infection progresses. The black line represents the
mean number of cells for each group. Results represent pups from 4-5 different litters.
Statistical analysis was applied by two-way ANOVA (* p<0.05, # p<0.001) with Bonferroni
post hoc test.
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3.3.9 Greater CD4 T cell infiltration in adults compared to neonates regardless of IFN 
expression
We next determined whether there were age-dependent differences in the number of Tcells infiltrating into the brain (Figure 18). CD46+ and CD46+/IFN-KO adults have a
significantly higher number of CD4 T cells compared to neonates of both genotypes in infected
whole brain tissue (Figure 18A, p<0.05).

CD8 T cells in CD46+/IFN-KO adults are

significantly higher compared to MV-infected neonates (Figure 18B, p<0.05). However, in the
CD46+ genotype, there is no difference in the number of CD8+ T cells between adults and
neonates. Additionally, in contrast to the neonates, there is no difference in the T cell numbers
between CD46+ and CD46+/IFN-KO adults.
We also determine the ratio of CD4:CD8+ T-cell in adult and neonatal CNS. CD46+
adults (5.9:1), CD46+/IFN-KO adults (2.6:1), and CD46+/IFN-KO neonates (2.9:1), skew
towards CD4+ T-cells. Whereas CD46+ neonates (0.5:1) have a ratio that is skewed towards
CD8 T-cells. Of note, only CD46+ adult mice can control MV in the CNS (O'Donnell, Conway,
2012). This suggests that CD46+ neonates may lack adequate CD4+ T cell helper function,
which may contribute to the relatively high viral load and poor pathological outcome.
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Figure 18.

Figure 18. CD4 T cell infiltration in the CNS is greater in MV-infected adults than in
neonates.
Whole brain homogenates from neonatal and adult CD46+ (A) and CD46+/IFN-KO (B) mice
were analyzed for infiltrating T cells at 7 dpi. Flow cytometry was performed for CD4 T cells
(CD3+/CD4+/CD19) or CD8 T cells (CD3+/CD8+/CD19-). Mice from 4-5 different litters were
compared for each condition. Statistical analysis was applied by two-way ANOVA (* p<0.05)
with Bonferroni post hoc test.
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3.3.10. B-cell infiltration at later stages is IFN independent
B-cells play a protective role during RNA virus infection such as Sindbis virus, Semliki
Forest virus, rabies virus, and neurotropic coronaviruses (Fragkoudis et al. , 2008, Griffin et al. ,
1997, Hooper et al. , 2009, Levine et al. , 1991). Studies in murine CMV models observe the
infiltration of B-cells that produce mCMV specific antibodies (Ab) (Mutnal et al. , 2012). In
adult CD46+ mice, B-cells are not required for survival or control of the virus (Solomos et al. ,
2016). In neonates, there is a significant increase in B-cell numbers from 7 to 10 dpi in the
absence of IFN (Figure 19). But in CD46+ neonates, there is no differences in B-cell
infiltration as the infection progresses. When compared across genotypes, CD46+/IFN-KO
neonates show significantly higher influx of B-cells compared to age matched CD46+ neonates
at 10 dpi. Thus, this suggest that there may be a blood-brain-barrier breakdown in the absence
of IFN at the later stages of infection, which allows for entry of B-cells into the CNS.
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Figure 19.
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Figure 19. B-cell infiltration is IFN independent at later stages of infection.
Flow cytometry was performed on whole brain homogenates for B cells (CD3-/CD19+). Bcells were quantified in MV-infected CD46+ and CD46+/IFN-KO neonates at 7 and 10dpi.
Black line represents the mean number of cells for each group. Results represent pups from
4-5 different litters. Statistical analysis was applied by two-way ANOVA (* p<0.05, # p<0.001)
with Bonferroni post hoc test.
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3.4

Discussion
The goal was to define the course of pathology and immune cell infiltration in the

neonatal brain during a viral infection. In the current study, CD46+ pups lacking IFN succumb
earlier to the infection despite greater infiltration of neutrophils and T cells than in wildtype
pups, which highlights the pleiotropic nature of this cytokine in influencing both leukocytes.
We demonstrated that the neonates mount an innate immune response with microglial activation,
NK cell, neutrophil and inflammatory infiltration in the brain. In CD46+/RAG2-KO mice, the
neonatal innate response is capable of delaying mortality and disease. But despite this, neonates
of all genotypes succumb to the infection. Our findings are consistent with the observation that
neonatal immune responses are often ineffective at controlling viruses and other pathogens
(reviewed in (Rouse and Sehrawat, 2010).

We characterized the role of the Th1 cytokine IFN during a neonatal immune
response in the brain because IFN is indispensable for neuronal clearance of many different
viruses (Burdeinick-Kerr, Wind, 2007, Chesler et al. , 2004, Komatsu et al. , 1996, Larena,
Regner, 2013, Patterson, Lawrence, 2002). However, it is important to note that IFN also
plays both pro- and anti-inflammatory roles in a variety of pathological conditions (Muhl and
Pfeilschifter, 2003), in addition to roles in host defense. We reasoned that IFN may be
protective in the developing CNS during an infection, where neurogenesis and synaptic
refinement are active. We have previously shown that IFN protects neural stem cells, but not
newly-differentiated neurons, in MV-infected CD46+ neonates (Fantetti et al. , 2016).
Although IFN maintains the neural stem cell pool during infection, it does not preserve
neurogenesis, demonstrating that IFN can prevent neural stem loss but cannot prevent loss of
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function. In the current study, CD46+ pups lacking IFN succumb earlier than wildtype pups,
which highlights the pleiotropic nature of this cytokine in influencing both lymphocyte and
neural cell activity. This finding also is consistent with models of experimental autoimmune
encephalitis, where IFN-knockout mice demonstrate more severe inflammation in the brain
(Willenborg et al. , 1999). Studies in IFN receptor deficient mice infected with sindbis virus
show greater infiltration of CD3+ T cells and perforin+ cells and more intense inflammation
in the CNS compared to wildtype mice (Lee et al. , 2013). Thus, further studies will determine
if CD46+/IFN-KO neonates express a more pro-inflammatory cytokine profile in the brain,
which would parallel the increased T cell infiltration at late stages of infection (Chapter 4).

The innate immune cells are the first responders of host defense against pathogens and
are mediated by phagocytes such as macrophages and dendritic cells. Innate immunity may
also contribute to early viral control, even if it is not responsible for the ultimate resolution of
infection in the brain. There were no differences in microglial morphology or intensity of
Iba1 staining in the presence and absence of IFN. This result was surprising because
microglial cells are exquisitely sensitive to IFN. Therefore, this suggests that compensatory
cytokines may be activating the microglia in CD46+/IFN-KO. Resident microglia
(CD45+(int) and CD11b(+)) do not express MHC class II in resting state. Microglia, become
activated either in response to virus or IFN and upregulate MHC II (Hamo et al. , 2007).
Studies in murine CMV suggest that upregulation of MHC II on microglia and high CXCL2
expression may lead to high infiltration of neutrophils. Thus, MHC II is a marker of
microglial activation and in some cases may indicate an exaggerated neuroinflammatory
process in the brain (Mutnal, Cheeran, 2010). Thus, further studies to address the differences
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in MHC II expression may provide insights on microglial activation and how genetic
deficiencies impact this.

Natural killer cells can be significant producers of IFN during viral infections ((Biron,
Nguyen, 1999)). We observed that there are no differences in NK cell infiltration (Figure 14)
between CD46+ and CD46+/IFN-KO pups. Because NK cell cytotoxicity is highly dependent
upon the type of cytokine stimulation, it is conceivable that the inflammatory milieu in
CD46+/IFN-KO pups encourages greater cytotoxic activity in NK cells (Lauwerys et al. ,
2000), which may contribute to greater pathology. Another possibility is that the cytokine
milieu in neonates does not activate the microglia in a manner that is favorable for viral
clearance or antigen presentation.

Additionally, children with herpes encephalitis show

deficiencies in NK cell function. There is also evidence of NK cells being neurotoxic as well
as neuroprotective (Reviewed in (Poli, Kmiecik, 2013)). Thus, further studies to explore the
functional differences in neonatal NK cells to adult NK cells may explain the differences in age
dependent outcome of infection.

Neutrophils in circulation respond to proinflammatory, chemotactic signals and
migrate to injured and infected tissue. Neutrophils play a role in extracellular bacterial
infections and several viral infections. Studies indicate that in the absence of antiinflammatory cytokines such as IL-10, high numbers of neutrophil enter the brain and cause
neuropathology (Jeong et al. , 2009, Mutnal, Cheeran, 2010). Thus, in the absence of IFN,
infiltration of excessive neutrophils and inflammatory monocytes may contribute to edema
and neuropathology. There is evidence that neutrophils have destructive potential through

91

neurotoxic effects through the release of proteolytic enzymes (Allen et al. , 2012, Stowe et
al. , 2009). Neutrophil activation during viral infections also leads to tissue damage (Drescher
and Bai, 2013, Stout-Delgado et al. , 2009). C57Bl/6 mice infected with influenza A virus
require IFN to modulate neutrophil activity in the lung and prevent tissue pathology (Stifter
et al. , 2016). Thus, the heightened numbers of neutrophils, along with a lack of modulation of
neutrophilic activity by IFN, may play a role in neuropathology in the CD46+/IFN-KO
neonates. It will be interesting to study the differences in neutrophils in the adult CNS and
compared it to neonates. This may help understand the inherent age dependent functionality
of neutrophils in the brain.

From these results, we can conclude that the neonatal immune response is capable of
inducing infiltration of innate immune cells in the CNS, but may struggle with the extensive
viral load that is produced in developing neurons. Neurotropic viruses spread readily in less
mature or newly-differentiated neurons, which may pose a greater challenge for viral control
and clearance in the developing brain (van den Pol et al. , 2002). This notion is supported by
the observation that MV-infected neonates exhibit more widespread expression of viral antigen
in multiple brain regions prior to T cell infiltration, which suggests that the virus spreads readily
in neonatal brain tissue. Thus, further studies will look at the difference in infiltration of Tcells which were critical for clearance in the adult CNS.

Neonates had the highest levels of neutrophil (Figure 15) and T cell infiltration (Figure
16) in the absence of IFN, and succumbed to the infection sooner than other genotypes. This
finding contrasts with CD46+/RAG2-KO neonates, which lack mature T cells and show
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delayed mortality. Although we do not yet understand whether such a T cell response could
contribute to neuropathology, these findings suggest that the lack of adaptive immune response
may be beneficial to survival in the infected neonates. Other models of viral CNS infections,
including some strains of west nile virus and dengue virus, show that the CD8 T cell response
induces immunopathology while also providing protection against the virus (An et al. , 2004,
King et al. , 2007). Cytotoxic T cells also play a more pathogenic role during infections with
Murray Valley encephalitis virus, where mice lacking granule exocytosis showed prolonged
survival (Licon Luna et al. , 2002). Of note, while providing evidence for a detrimental role
for T cell activity during a CNS infection, these studies were performed on adult mice, which
contrasts with findings in the adult CD46+ model where viral control is not associated with
immunopathology. An outstanding question is whether age-dependent function of T-cell will
dictate whether an anti-viral response will result in immunopathology.

Adult CD46+ mice depend upon CD4 T cells in concert with CD8 T cells or B cells in
order to survive a CNS infection with MV (Solomos, O'Regan, 2016, Tishon et al. , 2006). The
deletion of CD4 T cells alone results in death of adult CD46+ mice, whereas depletion of CD8
T cells is associated with less viral control but no changes in survival (Solomos, O'Regan, 2016).
Studies in other transgenic model suggest that CD4, CD8 or B-cells cannot control acute MV
infection alone. A combination of either CD4 T cell and B cells or CD4 and CD8 Tcell are
essential to control measles virus infection in the CNS (Tishon, Lewicki, 2006). Within the
adult brain, the CD4:CD8 T cell ratio revealed a greater proportion of CD4 T cells (5.9:1;
Figure 18). In C57/Bl6 mice, which are the background strain of the CD46+ model, the
CD4:CD8 ratios are relatively low in the spleen, as we also observed in splenocytes from the
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CD46+ adult mice (1.7:1; data not shown) (Myrick et al. , 2002). During many viral infections,
the CD4:CD8 ratio reverses to greater proportion of CD8 T cells, where the CD8 T cells become
necessary for viral clearance either through cytolytic or non-cytolytic mechanisms (Callan et
al. , 1996, Tripp et al. , 1995). The high CD4:CD8 ratio in the adult CD46+ brains, where viral
clearance is successful, may suggest that a greater proportion of CD4 help is required to respond
to neuronal infections non-cytolytically. These observations in MV-infected adult mice contrast
with our findings in CD46+ pups, where the CD4:CD8 ratio skewed toward greater CD8 T cells
(Figure 16). One possibility is that the low proportion of CD4 T cells does not provide
sufficient stimulation to the CD8 T cells to contribute to a non-cytolytic response. Support for
this idea is found in a model of neurotropic mouse hepatitis virus infection, where depletion of
CD4 T cells impaired the anti-viral function and survival of infiltrating CD8 T cells (Phares et
al. , 2012). Thus, it is possible that the lack of adequate number of CD4 T cells in neonates
may lead to inefficient activation of effector CD8 T-cells and loss of viral clearance.

In contrast, CD46+/IFN-KO neonates, which had the highest level of T cell infiltration
(Figure 16C and 16D), succumbed to the infection sooner than the other genotypes. These
findings support the notion that a lack of a neonatal adaptive immune response may be
protective in the brain. Other models of viral CNS infections, including some strains of west
nile virus and dengue virus, show that the CD8 T cell response induces immunopathology while
also providing protection against the virus (An, Zhou, 2004, King, Getts, 2007). Cytotoxic T
cells also play a more pathogenic role during infections with Murray Valley encephalitis virus,
where mice lacking granule exocytosis showed prolonged survival (Licon Luna, Lee, 2002).
Of note, while providing evidence for a detrimental role for T cell activity during a CNS
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infection, these studies were performed on adult mice, which contrasts with findings in the adult
CD46+ model where viral control is not associated with immunopathology. An outstanding
question is whether there are age-dependent changes in T cell activity that dictate whether an
anti-viral response will result in immunopathology.

A second possibility is that the expression of IFN limits T cell infiltration into the brain,
thereby limiting cytotoxicity. Previous studies in respiratory syncytial virus (RSV)-infected
neonates demonstrate that IFN expression in the lung leads to reduced recruitment of CD4 and
CD8 T cells (Eichinger et al. , 2015). Thus, a lack of IFN expression may allow for greater
recruitment of immune cells into the CNS in CD46+/IFN-KO neonates, thereby contributing
to greater immunopathology. T cells also play a more pathogenic role during infections with
Murray Valley encephalitis virus, where mice lacking granule exocytosis showed prolonged
survival (Licon Luna, Lee, 2002). Of note, while providing evidence for a detrimental role for
T cell activity during a CNS infection, these studies were performed on adult mice, which
contrasts with findings in the adult CD46+ model where viral control is not associated with
immunopathology. CD4 T cells were shown to play a major role in protection from MV
infection. However, in our system, CD4 T cells do not act independently to control MV
infection as reported earlier for MV and for murine gammaherpesvirus (Finke and Liebert,
1994) (Sparks-Thissen et al., 2005). Instead, CD4 T cells in conjunction with B cells or with
CD8 T cells are required to abort acute MV infection in the vast majority of MV infected mice.
These results indicate that control of MV may be dependent on multiple lymphocyte subsets
and not on a single lymphocyte subset. Although, we observed high T-cell and B-cell infiltration
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in the absence of IFNγ, these neonates succumb early to infection (Figure 7), suggesting that
there are likely functional differences in these lymphocytes that are not present in adults.

From these results, we observe that neonatal immune response is capable of inducing
elements of a successful adult response in the brain, including robust infiltration of T-cells, Bcells and NK-cells, but may struggle with the extensive viral load that is produced in the
developing neurons. Neurotropic viruses spread readily in less mature or newly-differentiated
neurons, which may pose a greater challenge for viral control and clearance in the developing
brain (van den Pol, Reuter, 2002). This notion is supported by the observation that MV-infected
neonates exhibit more widespread expression of viral antigen in multiple brain regions prior to
T cell infiltration, which suggests that the virus spreads readily in neonatal brain tissue (Figure
8). The combination of aggressive viral spread may overwhelm the neonatal CNS.
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CHAPTER 4
Neonates succumb to the infection despite a Type I and II interferon expression in the
CNS

4.1 Hypothesis: Neonatal immune response will be deficient in the expression of anti-viral
cytokines during both early and late responses to a CNS infection.

4.2 Rationale
Neonatal immune response to peripheral infections results in induction of distinct
cytokine profile when compared to an adult response against the same pathogen (reviewed in
(Adkins, Leclerc, 2004)). Depending upon the type and dose of antigen, neonatal T cells often
skew towards a Th2-like response (including production of IL-4, IL-5, and IL-13) as opposed
to a Th1 response, characterized by the production of IFN and TNF (Zaghouani, Hoeman,
2009). During a CNS infection, one could hypothesize that a Th1 response would be preferred
in order to ensure adequate IFN expression and control viral replication in developing neurons
while minimizing neuronal loss. However, IFN also has been shown to play both neurotoxic
and neuroprotective roles for developing neurons, making the influence of IFN in controlling
neonatal infections in the brain less clear (Mizuno, Zhang, 2008, O'Donnell, Henkins, 2015).
Additionally, Type I IFNs (IFNα and IFNβ) also regulate various arms of the immune
response against infections and have autocrine and/or paracrine effects. They promote the
expression of IFN-stimulated genes (ISGs) during an anti-viral immune response, which can
protect both infected and uninfected cells from viral replication (Borden et al. , 2007, Schoggins
et al. , 2011). When neurons are infected, they quickly initiate a protective type I IFN response.
IFNβ is an immediate early IFN that is produced by neurons and glia (Erlandsson et al. , 1998).
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The production of IFNβ over IFNα may be neuroprotective as IFNα contributes to greater
neurotoxicity. The type I IFN response slows virus spread and constrains virus replication
before the induction of a virus-specific adaptive immune response. Studies in CD46+ MVinfected adults suggest that type I IFNs are dispensable for viral clearance in CNS neurons
(Cavanaugh, Holmgren, 2015). Rather, viral clearance in the adult CD46+, CNS is mediated by
CD4+ T-cells and IFN production (Solomos, O'Regan, 2016). Age-dependent effects of Type
I and Type II IFNs in the brain post neurotropic infection are not well understood. Thus, we
explored the differences in the cytokine and chemokine response in the neonatal brain to
identify the shortcomings or deficits compared to an adult CNS.

Studies have suggested that neonates have a predominant Th2 response during
peripheral infections (Adkins, Leclerc, 2004) (Lambert et al. , 2014), which is an aberrant
response during viral infections. But in context to the neonatal brain and neutrotropic infections,
this response has not been studied. Thus, the initial hypothesis was that neonates may express
a Th2-biased cytokine response in the CNS and this may contribute to ineffective viral clearance.
Based on the results from the PCR array, our data suggests that a both neonates and adults
exhibit a Th1 phenotype in the brain at 7dpi. Despite this, the CD46+ neonates succumb to the
infection (Figure 7). Therefore, we examined factors beyond the Th1/Th2 bias and focussed
on early innate, Type I IFN response and its surrogate markers as well as downstream signalling
of IFN. As the virus is high at 4 dpi (Figure 8), prior to robust NK and T-cell accumulation,
the role of early IFNs and the potential deficits in downstream IFNs signaling may explain the
lack of viral control in neonates.
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4.3 Results

4.3.1 MV-infected neonates upregulate Th1 cytokine and chemokine genes in the CNS
To address the age dependent differences in chemokine/cytokine production, we examined the
mRNA expression of 84 cytokine and chemokines genes in the MV-infected adult and neonatal
brains using a qRT-PCR array. Table 1 lists genes that were significantly upregulated by ≥2
fold in the MV-infected neonates and adults compared to their age-matched, uninfected controls.
Classical Th2 cytokines such as IL-4, IL-5, and IL-13 were not upregulated in either MVinfected neonates and in the adult CNS. Rather, many Th1-associated cytokines were
upregulated in comparison to uninfected controls at both ages (p< 0.05; Table 4, top panel).
Among the Th1-associated factors, IFN (11-fold in neonates, 8-fold in adults), IL-1β (3-fold
in adults and neonates) and chemokine (C-X-C motif) ligand 10 (Cxcl10; 85-fold in neonates,
44-fold in adults) were upregulated during MV infection at both ages. The anti-inflammatory
cytokine interleukin-1 receptor antagonist (IL1rn) is also upregulated in neonates (17.84-fold)
and adults (14.4-fold) post-infection, as well as the expression of several other chemokines
genes (Ccl12, Ccl3, Ccl4, Ccl5, Cxcl11 and Cxcl13). Both adults and neonates do not
upregulate IFNα2 post MV infection. These data suggest that the expression of many
inflammatory genes is age-independent in the brain.
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Table 4.

Table 4. Gene expression of pro- and anti-inflammatory cytokines in MV-infected
neonatal and adult brains.
Gene expression of cytokines and chemokines in measles virus-infected neonatal and adult
brains. Brain tissue from uninfected and MV-infected CD46+ neonates and adults were
collected for RNA extraction at 7 dpi. qRT-PCR array analysis was performed using the RT2
Profiler™ PCR Array. Changes in the gene expression that were more than two-fold relative
to the uninfected controls are shown. For infected mouse brains (n = 16) and for uninfected
(n=8) were used for adults and neonates. All data were normalized against levels of
housekeeping genes within the same sample. *p< 0.05 by students t-test.
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Additionally, neonates and adults also upregulate unique subsets of genes in an agedependent manner during infection (Table 4, middle and bottom panel). The expression of
tumor necrosis factor (TNF) is significantly increased in MV-infected neonates, but not in
adults. Interleukin 10 (IL-10), a global suppressor of the immune response (Moore et al. ,
2001), was the only Th2-related cytokine to be upregulated in MV-infected neonates. CCL2,
which is associated with reduced microglial/macrophage activation in adult infection with
mouse hepatitis virus (MHV), is elevated only in infected neonates (Trujillo et al. , 2013).
MV-infected adults also expressed unique inflammatory genes that were not activated in the
neonates. Adult mice show increased expression of the IFN-inducible gene CXCL9 (17.67fold) (Brice et al. , 2001), which suggests that IFN-responsive gene expression may be
partially dependent on age. Of note, gene expression in uninfected neonates and adults
revealed modest baseline differences in the absence of infection (Table 7). For example,
adult mice expressed higher baseline levels of IL-12a (3.98-fold), IL-17a (2.13-fold), and IL-2
(2.13-fold) in the brain than uninfected neonates. Of these cytokines, IL-12a was the only
factor to be upregulated by the neonates upon infection (7.87-fold versus uninfected neonates,
Table 1). Together, this data suggests that the majority of cytokines/chemokines that are
induced upon infection are distinct from factors that show an age-dependent difference in
uninfected controls.

We also wanted to address the differences in survival between the immunocompetent
and immunocompromised neonates. In order to define any variation in the cytokine profiles in
infected neonates, we examined the cytokine expression in CD46+, CD46+/IFN-KO and
CD46+/RAG2-KO neonatal brains (Table 5). CD46+/IFN-KO and CD46+/RAG2-KO
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neonates expressed unique subsets of genes that were not upregulated in the immunocompetent
CD46+ mice. CD46+/IFN-KO neonates upregulated CXCL1 in the brain, which can act as a
neutrophil chemoattractant and may partially explain the greater neutrophil infiltration
observed in these mice (Figure 15A) (Bozic et al. , 1995). Surprisingly, CD46+/IFN-KO
neonates also upregulated CXCL9, which is classified as an IFN-inducible gene, suggesting
that IFN-independent pathways may also regulate CXCL9 expression in the CNS. The
CD46+/RAG2-KO neonates, which demonstrated less mortality during infection, activated a
number of genes that were not observed in the other neonates (Table 5, bottom panel). Various
cytokines (IL-5, IL-7, IL-15, and bone morphogenic proteins (BMP) 2, 4, 6, and 7) and
chemokines (CCL11, CCL17, CCL19, CCL22, CXCL16) were induced only in CD46+/RAG2KO brains upon infection.

However, comparison of the baseline gene expression between

uninfected neonates demonstrates that CD46+/RAG2-KOs have lower basal expression of
some of the factors that are upregulated during infection (e.g. the BMPs, CCL11, and CCL17;
(Table 6) in comparison to the uninfected CD46+ neonates. Thus, although the CD46+/RAG2KO neonates express many unique genes upon infection, a subset of these genes are expressed
endogenously at low basal levels.

As seen in the CD46+ neonates and adults, there was overlap in the expression of some
Th1-related factors in the neonatal mice. CXCL10 showed the greatest induction in all infected
neonates: CD46+ (84.6-fold), CD46+/IFN-KO (291.4-fold) and CD46+/RAG2-KO neonates
(771.1-fold). IFN is upregulated in the CD46+ (11.1-fold) and CD46+/RAG2-KO neonates
(15.0-fold), suggesting that innate immune cells are contributing to IFN production the
absence of T cells. With the exception of IL-10, genes that were activated in the CD46+
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neonates but not in the CD46+ adults (Table 4, middle panel) also were expressed in
CD46+/IFN-KO and CD46+/RAG2-KO neonates. For example, TNF is upregulated in CD46+
(8.4-fold), CD46+/IFN-KO (17.9-fold) and CD46+/RAG2-KO (72.1-fold) neonates, but there
is no upregulation in the adults. In addition, genes that were only expressed in the CD46+
adults when compared to CD46+ neonates (e.g. CXCL9, CCL11; Table 4, bottom panel) were
all expressed in the CD46+/RAG2-KO neonates upon infection. Thus, the CD46+/RAG2-KO
neonates express a cytokine profile that includes factors that are controlled in an age-dependent
manner in the immunocompetent CD46+ mice.
In addition to understanding the genes that are upregulated post infection, we wanted
to understand the baseline differences in cytokine expression due to genetic deficiencies.
Thus, in Table 6, basal gene expression in uninfected CD46+/IFN-KO and CD46+/RAG2KO neonates are compared to uninfected CD46+ neonates. As expected, IFN and IFN
inducible CXCL11 is downregulated in CD46+/IFN-KO neonates. In CD46+/RAG2-KO
neonates show downregulated Bmp 2, 4, 6, and 7 expression compared to CD46+ uninfected
neonates. There were no baseline differences in IFNα and chemokines like CXCL10 and
CCL2 among all the neonates (Table 6).
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Table 5.
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Table 5: Gene expression of cytokines and chemokine in measles virus-infected
CD46+, CD46+/IFN-KO and CD46+/RAG2-KO neonates. Brain tissue was collected from
uninfected and infected neonates and RNA was extracted at 7 dpi. qRT-PCR array analysis
was performed using the RT2 Profiler™ PCR Array. For each infected neonatal group (n=16)
was used in the array. Changes in the gene expression that were more than two-fold relative
to the uninfected controls are shown. All data were normalized against levels of
housekeeping genes within the same sample. *p< 0.05 by students t-test.
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Table 6.

Table 6: Baseline mRNA expression of cytokines/chemokines in uninfected neonatal
brains. Brain tissue from uninfected CD46+, CD46+/IFN-KO, and CD46+/RAG2-KO
neonates was collected for RNA extraction. qRT-PCR array analysis was performed using
the RT2 profiler PCR Array. Changes in gene expression that were more than two-fold higher
(blue) or more than two-fold less (red) relative to the uninfected CD46+ neonates are shown.
All data were normalized against levels of housekeeping genes within the same samples.
Genes with P values less than 0.05 are shown (student t-test).
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In Table 7, the baseline differences in cytokine expression between adult CNS and neonatal
CNS are compared. The adult CNS shows downregulated Bmp4, CCL20 and Tnfsf11
expression. There are no differences in any Type I or Type II IFN expression between adults
and neonates.
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Table 7:

Table 7: Baseline mRNA expression of cytokines/chemokines in uninfected neonatal
and adult brains. Brain tissue from uninfected CD46+ neonates and adults was collected for
RNA extraction. qRT-PCR array analysis was performed using the RT2 profiler PCR Array.
Changes in uninfected adult gene expression that were more than two-fold higher (blue) or
more than two-fold less (red) relative to the uninfected CD46+ neonates are shown. All data
were normalized against levels of housekeeping genes within the same samples. Genes with
P values less than 0.05 are shown (student t-test).
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4.3.2 CD46+ neonates and adults differentially express PRRs and Type 1 interferons
during infection
Our previous data suggests that adult mice may depend on the Type I interferons early in
infection, whereas IFN is required for later control and resolution of the infection
(O’Donnell, et al. 2012). Furthermore, evidence from the Rall laboratory shows that
embryonic hippomcampal neurons from the CD46+ mice express relatively high endogenous
levels of IFNα/ compared to other cell types, although the Type I interferons were
dispensable for survival in vivo (Cavanaugh, Holmgren, 2015). The data in Table 4 and Table
5 suggests that neonates succumb to the infection despite a Th1 cytokine response. However,
we had not explored the Type I IFNs, which are typically expressed at earlier time points in
infection, because they were dispensable for ultimate viral control in adults. In a canonical
infection model, IFNβ is produced after recognition of viral PAMPs by PRRs. IFNβ binds to
IFNαR leading to IRF7 gene expression to enable a full type I IFN response. In vivo studies in
Theiler’s virus and La Crosse brain infection led to production of type I IFN response by
ependymal cells, neurons, and macrophages (Delhaye, Paul, 2006). Thus, we wanted to
explore whether age-related differences in the type I IFN response could contribute to loss of
viral control in neonates.

Our array data suggested that IFNα2 was not expressed at significant levels in either
neonatal or adult mice brains during infection (data not shown). We also wanted to determine
if our gene expression data correlated with protein expression. This was to ensure that the
mRNA translated into protein and that mRNA degradation does not occur. Thus, we
attempted to analyze protein levels of IFNα/ IFNβ through multiple methods. We attempted to
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measure 14 of the IFNα isoforms through an ELISA at 3 and 7 dpi. However, we could not
detect any difference in IFNα protein expression between uninfected and MV-infected
neonates and adults (Figure 20). This suggests that IFNα expression at early stages of
infection may be low or the background signal for the ELISA may be too high to detect subtle
changes. We also attempted to address protein levels by western blot analyses of hippocampal
brain tissue at 3, 7, and 10 dpi using a variety of antibodies for IFNα and IFNβ.
Unfortunately, we were unable to detect differences in IFNα/ proteins at any time point
using western blot analysis. This data suggests that basal expression of IFNα may not change
dramatically during early stages of infection (Cavanaugh, Holmgren, 2015).

As an alternative approach, we instead measured IFNα/ mRNA levels by qRT-PCR
in the RNA samples, as we have this technique to be more sensitive in our hands (Figure 21).
We found that the neonatal mice expressed IFNα4 and IFNβ during infection at 7 dpi,
whereas the adult mice did not show an appreciable increase in expression (Figure 21).
These data correlate with our previously published observations on STAT2 activation in
neonates, in which hippocampal tissue from CD46+ and CD46+/IFN-KO neonates show
STAT2 phosphorylation at the same time point (Fantetti, Gray, 2016). We looked at 3 dpi
and 7 dpi to understand if there any differences in early type I IFN induction. Early in
infection (3 dpi), we did not observe significant expression of IFNα4 or IFNβ in the adults or
neonates of any CD46+ genotype (Figure 21A, 21B). As the infection progressed (7 dpi),
CD46+/IFN-KO neonates upregulated IFNα4 (29-fold) to a greater extent in comparison to
CD46+ (7.5-fold) and CD46+/RAG2-KO (5.7-fold) neonates post-infection, whereas CD46+
adults did not increase the expression of IFNα4 significantly (Figure 21A, 21B). In contrast,
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CD46+/RAG2-KO neonates demonstrated greater upregulation of IFNβ in comparison to
other neonates (1644.8-fold; Figure 21C). Although IFNβ also was upregulated in the CD46+
neonates (122-fold) at 7 dpi, CD46+ adults did not show significant upregulation of IFNβ at
either time point (Figure 21D). Thus, IFNβ upregulation in CD46+/RAG2-KO neonates may
contribute to their early viral control and greater survival. We also analyzed levels of the
IFN-responsive gene (ISG), Melanoma Differentiation-Associated protein 5 (MDA5), which
is a PRR, as a surrogate for Type I IFN signaling. MDA5 was not induced significantly in
infected CD46+ neonates or adults at either time point (Figure 21E, 21F). At 7 dpi, only the
CD46+/IFN-KO neonates significantly upregulated MDA5, which may correlate with the
elevated IFNα4 observed at this time point.
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Figure 20.
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Figure 20. IFNα protein expression in adult and neonatal CNS post infection at 3dpi.
Brain tissue was isolated from infected and uninfected neonate and adult brains and protein
was extracted at 3 dpi. Protein concentration was measured by protein assay and equal
protein was loaded into each well of the ELISA to detect total IFNα (14 isoforms). One-way
ANOVA was used to determine statistical significance.
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Figure 21.

Neonates
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Figure 21. Neonatal mice induce greater expression of Type I interferons during MV
infection in comparison to adults.
Brains of uninfected and MV-infected CD46+ mice were analyzed for the mRNA expression
of Type I interferons at 3 dpi and 7 dpi. CD46+, CD46+/IFN-KO, and CD46+/RAG2-KO
neonates (left column; A, C, E) and CD46+ neonates and adults (right column; B, D, F) were
compared. qRT-PCR analysis was performed for IFNα4 (A, B), IFNβ (C, D) and MDA5 (E,
F). Relative gene expression is shown as the fold-change normalized to the CD46+
uninfected controls (n=4-5 mice/condition).

Each bar represents the mean fold-change and

SEM. Statistical differences were determined by three-way ANOVA (* p<0.05, # p<0.001)
with Bonferroni post hoc test.
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4.3.3 MV-infection induces distinct expression of pattern recognition receptors in the
neonatal and adult CNS.
Although it is possible that other IFNα isoforms are expressed in the infected adults or
neonates, we further looked at other PRRs that sense RNA virus such as RIGI, TLR3, and
TLR7 to explore age dependent differences upstream of Type I IFNs. As we did not observe
an early induction of Type I response at 3 dpi, we explored the changes of other PRRs at the 7
dpi timepoint only (Figure 22). For our analysis, we focused on RIGI, which is expressed in
the brains of MV-infected transgenic mice expressing Hsp70, and TLR 3 and 7, which
recognize viral RNAs (Kim et al. , 2013, Sorgeloos et al. , 2013). TLR3, in particular, has
been shown to be induced by the MV-Edmonston strain in cell lines (Tanabe, KuritaTaniguchi, 2003). During infection of CD46+ mice, both CD46+ and CD46+/RAG2-KO
neonates upregulate RIGI (12.2-fold and 24.4-fold respectively, Figure 22A) in the brain,
whereas infected CD46+ adults did not demonstrate significant upregulation of RIGI with
infection (Figures 22B). CD46+ neonates did not upregulate either TLR3 or TLR7 (Figure
22C and 22E), while CD46+/IFN-KO neonates upregulated TLR3 (41-fold, Figure 22C)
and CD46+/RAG2-KOs upregulated TLR7 (11-fold, Figure 22E). In contrast, CD46+ adults
upregulate TLR3 (2.3x105-fold) and TLR7 (37.3-fold) to a greater extent than the any
genotype of the MV-infected neonates (Figure 22D and 22F). These results suggest that the
CD46+ adult mice may rely on the TLR family of proteins for recognition of the virus.
Additionally, these results suggest that gene expression of Type I IFN and associated ISGs
remain relatively low at the start of infection in both neonates and adults, when Type I IFN
expression would be expected to dominate. Thus, we propose that the less effective immune
response in neonates is not attributable to a diminished Type I IFN response.
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Figure 22.

116

Figure 22. MV-infection induces distinct expression of pattern recognition receptors in
the neonatal and adult CNS.
Brains of uninfected and MV-infected CD46+ mice were analyzed for the mRNA expression
of pattern recognition receptors (PRRs) at 7 dpi. CD46+, CD46+/IFN-KO, and
CD46+/RAG2-KO neonates (left column; A, C, E) and CD46+ neonates and adults (right
column; B, D, F) were compared. qRT-PCR analysis was performed for RIGI (A, B), TLR3
(C, D), and TLR7 (E, F). Relative gene expression is shown as the fold-change normalized
to the CD46+ uninfected controls (n=4-5 mice/condition). Each bar represents the mean foldchange and SEM. Statistical differences were determined by two-way ANOVA (* p<0.05, #
p<0.001) with Bonferroni post hoc test.
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4.3.4 IFN induction occurs independently of age, but activation of the IFN-responsive gene
CIITA occurs only in adults.
Finally, to confirm the results of the RT array, we examined the mRNA induction of
IFN in brain tissue through qRT-PCR at 7 dpi. Expression of IFN mRNA was higher in
CD46+ neonates compared to CD46+/RAG2-KO neonates (Figure 23A). Induction of IFN
mRNA was also greater in CD46+ neonates than in adults (Figure 23B). While we had
observed the induction of some IFN-responsive genes in both age groups (Table 1), adult mice
also expressed IFN-responsive genes that were not expressed in neonates (e.g. CXCL9),
suggesting that neonatal mice may have impaired IFN signaling.

To investigate the

downstream effects of IFN signaling, we compared the mRNA expression of CIITA (Class II
Major Histocompatibility Complex Transactivator), a critical regulator of MHC-II induction
and a IFN-responsive gene (Reith, LeibundGut-Landmann, 2005). There was no difference in
CIITA expression among the three genotypes of the neonates (Figure 23C), despite the
expression of IFN in CD46+ (4-fold) and CD46+/RAG2-KOs (2-fold) neonates. However,
CD46+ adults induced greater CIITA expression (11-fold) compared to uninfected controls and
compared to infected CD46+ neonates (Figure 23D), despite less expression of both IFN and
MV. These results suggest that although IFN may be induced in the brain during infection,
there may be deficiencies in IFN signaling or transcriptional activation in the neonatal brain.
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Figure 23.
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Figure 23. Despite elevated IFN expression during infection, transcription of IFNresponsive genes is age-dependent.
Brains of uninfected and MV-infected CD46+ mice were analyzed for the mRNA expression
of IFN and CIITA at 7 dpi. CD46+, CD46+/IFN-KO, and CD46+/RAG2-KO neonates (left
column; A, C) and CD46+ neonates and adults (right column, B, D) were compared. qRTPCR analysis was performed for IFN (A, B) and CIITA (C, D). Relative gene expression is
shown as the fold-change normalized to the CD46+ uninfected controls (n=4-5
mice/condition). Each bar represents the mean fold-change and SEM. Statistical differences
were determined by two-way ANOVA (* p<0.05, # p<0.001) with Bonferroni post hoc test.
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4.4 Discussion

Recognition of viral RNA by PRRs such as the RIG-I and the membrane bound TLRs lead to
the induction of Type 1 IFNs, which are significant early steps in viral control (Akira,
Uematsu, 2006, Yoneyama, Kikuchi, 2004, Zalinger, Elliott, 2015). As we observed greater T
cell infiltration in the adults despite a lower viral load than the neonates, we considered the
possibility that enhanced expression of pattern recognition receptors (PRRs), and subsequent
Type I IFN expression, could correlate with the relatively robust immune response that is
induced in adults. The type I IFNs, IFNα and IFNβ, both signal through the same receptor
(comprised of IFNAR1 and R2), but they exert different biological effects in the CNS.
Several studies suggest that IFNβ expression is associated with anti-inflammatory effects in
the CNS (Hua et al. , 1998, Lu et al. , 1995, McLaurin et al. , 1995). Whereas IFNα
expression has been associated with neuroinflammatory disorders and brain injury such as
HIV-associated brain injury and HIV-associated neurocognitive disorders (Sas et al. , 2009,
Sas et al. , 2007). Studies also suggest that transgenic expression of IFNα in the mouse CNS
results in progressive inflammatory encephalopathy and neurodegeneration (Akwa et al. ,
1998). Thus, it is possible that high IFNα expression may contribute to inflammation and
edema seen in CD46+/IFN-KO neonatal brains (Figure 21), which may lead to earlier death
despite a lower viral load (Figure 7 and 8).

In canonical Type I IFN signalling, production of IFNβ leads to the subsequent
induction of IFNα. But studies in SIV infection suggests that CCL2 binds to the CCR2
receptor on macrophages to selectively suppress IFNα induction without any effect on IFNβ
and antiviral ISG expression (Zaritsky et al. , 2012). Thus, a pronounced upregulation of
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CCL2 in CD46+/RAG2-KO CNS (493-fold – Table 2) may suppress IFNα in these brains
and inhibit IFNα-mediated neurotoxicity. Studies in HIV-gp120 transgenic mice and SIV
models suggest that IFNβ response is activated without the production of neurotoxic IFNα
(Thaney et al. , 2017). RIG-I, a PRR that is expressed in microglia, astrocytes, and neurons
and may contribute to endogenous production of IFNβ in the CNS (Furr et al. , 2008, Nazmi,
Dutta, 2011). We observe that CD46+/RAG2-KO neonates have highest RIG-1 expression in
the CNS which may correlate with higher IFNβ production in their brain (Figure 21 and 22).
Studies in human fetal microglia provide evidence that IRF3, a transcription factor, is required
for induction of IFNβ and contributes to the switch of microglia from pro- to antiinflammatory phenotype via the PI3K/AKT pathway (Tarassishin et al. , 2011). Thus, this
suggests that IFNβ may change the phenotype of microglia from proinflammatory to antiinflammatory/protective state. Therefore, it will be interesting to look at the differences in
IRF3 expression in the CD46+/RAG2-KO compared to CD46+ neonates post infection.
Additionally, a future direction for this project is to characterize the phenotype of microglia in
vivo to determine whether a predominant M1 or M2 phenotype occurs post neonatal MV
infection.

IFNβ also induces CCL4, a chemokine which is upregulated in the neonates (Figure
and Table 2). CD46+/RAG2-KO neonates show a robust upregulation of CCL4 post infection.
In vitro studies indicate the CCL4 protects cerebrocortical neurons against neurotoxicity
(Thaney, O'Neill, 2017). The IFN response is complex and hence, interplay of several factors
and ISGs such as CXCL10, CCL4, and CCL2 may contribute to neuronal rescue in
CD46+/RAG2-KO neonate compared to CD46+ neonates, which express low levels of IFNβ.
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Another possibility is that higher expression of RIG-1 and IFN in the CD46+/RAG2-KO
CNS than other neonates or adults (Figure 21) may lead to early viral sensing and subsequent
IFN help. Thus, this may help control CD46+/RAG2-KOs neonates to control the infection
better in the absence of adaptive immune cells. Furthermore, CD46+/RAG2-KO neonates
expressed a broader of array of cytokines/chemokines during infection than CD46+ neonates
or adults (Table 2). Among the factors that were upregulated only by the CD46+/RAG2-KO
neonates, the expression of multiple BMP family members (BMP 2, 4, 6, and 7) was elevated
during infection, although it is important to note that the BMP family members exhibited
lower basal expression in the CD46+/RAG2-KO mice prior to infection. Studies of neonatal
mice infected with reovirus show that BMP signaling is activated during CNS infection, and
that BMP6 protects virally-infected neurons from apoptosis (Beckham et al. , 2009). We
speculate that BMP expression in the CD46+/RAG2-KOs may confer a neuroprotective
advantage against the virus, which may help the CD46+/RAG2-KOs to resist succumbing to
the infection as readily as their wildtype counterparts.

CCL2, which functions as a chemoattractant for monocytes, macrophages, and T cells,
was upregulated significantly in CD46+ MV-infected neonates but not in adults. Transgenic
adult mice that express CCL2 in the CNS are ineffective at viral clearance and succumb when
infected with a neurotropic strain of mouse hepatitis virus (Trujillo, Fleming, 2013).
Overexpression of CCL2 is also associated with greater infiltration of regulatory T cells and
reduced microglial/macrophage activation with a mixed M1/M2 phenotype, which also was
associated with a suppressive phenotype (Trujillo, Fleming, 2013). Thus, overexpression of
CCL2 can lead to a defective immune response that fails to clear the virus and is both
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inflammatory and immunosuppressive. Although CCL2 is crucial for lymphocyte recruitment
and clearance of some viruses from the brain (Chen et al. , 2001), it is possible that expression
of CCL2 in MV-infected neonates contributes to a suppressive, M2-like phenotype in microglia.

CD46+ neonates upregulate RIGI expression post virus infection (Red) in the brain and may
activate downstream signaling cascade that result in Type I IFN (Interferon) production.
(Figure 24A) Macrophages, part of innate immunity sense viruses and engulf them by
phagocytosis and produce several cytokines such as IFNα, IFNβ, IL-12 and IL-27. These
cytokines further lead to activation of Natural killer cells. Both NK cells and macrophages may
also produce IFNγ that binds to IFNR on neurons and APCs. MHC-II encodes for genes that
are essential for presentation of antigen to CD4+ T-cell. The induction of MHC-II expression in
most cell types is modulated by exposure to IFN. In neonates, low expression of CIITA may
lead to low MHC-II and lead to loss of control to viral infection in the neonatal CNS (Figure
24A). This contrasts to what occurs in the adult CNS, where IFN signaling leads to higher
expression of CIITA (Figure 24B) that may lead to high MHC-II. Thus, adults exhibit effective
antigen presentation and IFN-mediated viral clearance.
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Figure 24.

Figure 24. Model of neonatal immune response in the brain
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Multiple studies have shown that neonates have poor Th1 function and a strong Th2
response during microbial infections (Forsthuber et al. , 1996, Powell and Streilein, 1990, Singh
et al. , 1996). This Th2 bias may be due to delayed maturation of accessory cells or intrinsic
epigenetic factors in neonatal T cells. (Li et al. , 2004). Regardless of the cause, Th2-like
responses are not typically associated with IFN production, which is a hallmark of Th1
responses. Given the significance of IFN in viral control in neurons, we predicted that the
failure of CD46+ pups to control MV would be due towards a Th2-bias in the brain. Although
distinct cytokine subsets were observed in infected CD46+ adults and neonates, the neonatal
mice did not demonstrate a clear Th2 bias. CCL2 can be important for the development of a
Th2 phenotype (Gu et al. , 2000), but other key Th2 factors (e.g. IL-4, IL-5) were not
upregulated in infected neonates. Rather, both adult and neonatal CD46+ mice expressed Th1associated cytokines and chemokines, including IFN, CXCL10, CCL3, and CCL5, during
infection. IFN-inducible genes, including CXCL10 and CXCL11, were also upregulated in
both infected neonates and adults, suggesting that there is a sufficient amount of IFN to activate
downstream transcriptional changes. However, neonatal CD46+ mice failed to activate both
CXCL9 and CIITA (Table 1 and Figure 11), both of which are IFN-inducible genes. These
findings suggest that IFN signaling may be limited in the neonatal CNS, at least in regard to
the profile of genes that are activated (Figure 24A). Previous studies in CD46+ neonates
demonstrate elevated expression and phosphorylation of Signal transducer and activator of
transcription 1 (STAT1), the major signaling molecule downstream of IFN, in the
hippocampus during infection (Fantetti, Gray, 2016). This observation implies that IFN
induces its canonical signaling cascade in the neonatal brain. However, both Type I and II
interferons signal through STAT1, so it is possible that STAT1 activation in neonates does not
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reflect robust IFN signaling per se. Regardless of the level of STAT1 activation, the disparity
in the activation of IFN-inducible genes suggests that the outcomes of IFN signaling may be
dictated by age-related factors (Figure 24).
Although CD46+ neonates and adults upregulated similar Th1 cytokines and
chemokines in the CNS, the expression of some cytokines during infection was age-dependent.
In addition to unique expression of CCL2, neonatal mice express the anti-inflammatory
cytokine IL-10, which is classically associated with Th2-like responses and repression of Th1
cytokine synthesis (Couper et al. , 2008). In the CNS, recombinant expression IL-10 is
protective against virally-induced demyelination and lymphocyte infiltration (Trandem et al. ,
2011a). Endogenous IL-10 also protects against neuropathology caused by coronaviruses and
flavivirues in murine models of adult infection (Trandem et al. , 2011b, Tun et al. , 2014).
However, the lack of IL-10 induction in CD46+ adult mice suggests that IL-10 is dispensable
for non-cytolytic viral clearance from neurons. Similarly, CD46+ neonates, but not CD46+
adults, upregulated TNF during infection. TNF is associated with neuroprotection in models of
flavivirus encephalitis (Hayasaka et al. , 2013, Tun, Aoki, 2014). Thus, it is surprising that both
IL-10 and TNF would be expressed in the neonatal CD46+ model, where viral clearance fails
and neuronal dropout is apparent, but not in the adult CD46+ model, where viral control is
successful. One possible explanation is that IL-10 induction in neonates dampens the expression
of necessary anti-viral or neuroprotective cytokines but does not completely inhibit them, which
may explain the extensive overlap in cytokine profiles between adults and neonates despite
disparate outcomes in viral control and survival.
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Age-dependent innate immune responses may also contribute to early viral control,
even if innate immunity is not responsible for the ultimate resolution of the virus. Previous
studies indicate that murine neonatal intestinal epithelial cells fail to express TLR3 in
response to rotavirus infection through post-natal days 1-10, which overlaps with the time
points reflected in our study (Pott, Stockinger, 2012). Similarly, human cord blood samples
do not induce TLR3 in response to poly(I:C) treatment or HSV activation in comparison to
adult NK cells (Slavica, Nordstrom, 2013). Although, we observed robust RIG-I expression
in the CD46+ neonates, there is also evidence in human neonatal dendritic cells that RIG-I
function is impaired and is associated with poor control of RSV (Marr et al. , 2014). In CNS
infections of HSV, TLR3 signalling is critical to control both primary HSV infection and its
reactivation. Humans with defects in TLR3 signaling are more susceptible to encephalitis
(Guo et al. , 2011, Zhang et al. , 2007). Nevertheless, neonatal mice demonstrated greater
induction of Type I IFN expression than adults at the time points examined, suggesting that
the neonatal mice are capable of detecting MV through other PRRs.

CD46+/RAG2-KO neonates show high expression of IFNβ at 7dpi. Although, type I
IFN may be dispensable for viral control in the adult CNS (Cavanaugh, Holmgren, 2015), IFNβ
may contribute to early viral control in the neonatal CNS. To fully characterize age-dependent
differences in Type I IFNs, the other isoforms of IFN would also have to be analyzed.
However, it is possible that in the absence of a fully developed T cell response, a Type I IFN
response can be especially impactful in the neonatal CNS. Additionally, exploring the role of
TLRs and their deficiencies in the neonatal CNS may provide future targets for therapeutic
intervention.
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5. Conclusions
The focus of this dissertation centered on dissecting the role of the neonatal immune
response during a viral CNS infection. We found that (i) interferon-gamma (IFN), a key
cytokine required for viral control in neurons in adults, delays mortality in neonates, (ii)
neonates ultimately succumb despite IFN-independent infiltration of natural killer cells,
neutrophils, inflammatory monocytes, and CD4 and CD8 T-cells (iii) neonates and adults
differentially express pathogen recognition receptors and Type I interferons during infection,
(iv) both neonates and adults express IFN, CXCL10, IL-1, and IL-1RA, among induction of
other Th1-associated factors cytokines/chemokines, in the brain but only adults control the
infection,

and

(v)

neonates

and

adults

also

express

non-overlapping

sets

of

cytokines/chemokines. The results suggest age-dependent expression of cytokine profiles in the
brain

and

distinct

dynamic

interplays

between

lymphocyte

populations

and

cytokines/chemokines in MV-infected neonates.

We had anticipated that neonatal mice would demonstrate major deficits in T cell
infiltration. Although we did observe lower T cell numbers in neonates at later time points, we
did not observe as much of a quantitative deficit as we had anticipated. Thus, we also
investigated potential deficits in innate immune cells. Here, we observed that NK cells,
neutrophils and inflammatory monocytes infiltrate into the neonatal brain post MV infection.
In the absence of IFN, highest numbers of NK cells, neutrophils, inflammatory monocytes, Tcells and B-cells accumulate into the CNS. These neonates succumb earliest to the neurotropic
MV infection in the brain. We hypothesized that IFN expression may be lacking in the CD46+
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neonatal CNS. However, surprisingly we found IFN expression in the brain but induction of
downstream signalling of CIITA is decreased in neonates compared to adults.

Our findings highlight the complex, age-specific responses of immune cells to a CNS
viral infection, and suggest that multiple cytokines likely contribute to successful viral
clearance from neurons. A major focus of future work is to better understand how the cytokine
milieu in adult mice affects viral clearance in neurons, and to determine if the cytokine profile
in neonates can be directed toward more effective viral clearance. Given that IFN was
expressed in both neonatal and adult mice, but distinct profiles of IFN-responsive genes were
induced, it suggests that there may be age-dependent differences in IFN signaling. Prior
studies by our laboratory have demonstrated cell type-specific differences in expression of the
IFN receptor and of intracellular signaling molecules (e.g. STAT1) in neural cells. As the
proportion and/or maturity of cells change in the CNS with age, it is conceivable that the
signaling pathways induced by IFN also change over time. How such age-dependent changes
affect the profile of the anti-viral program, and what cells are most affected by age-dependent
changes, remain an open question.

Future studies may employ adoptive transfer approaches to transfer adult T-cells into
the neonates to determine the age-dependent T-cell behaviour in the CNS. Additionally, the
mechanism of early viral control in CD46+/RAG2-KO neonates may be explored. IFNβ was
significantly upregulated at 7dpi in CD46+/RAG2-KO neonates. Therefore, further studies to
elucidate the role of IFNβ and its downstream signalling in the neonatal CNS may enhance our
understanding of Type I mediated viral control. BMPs were also upregulated only in the
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CD46+/RAG2-KO neonatal brains. There is evidence for BMPs being neuroprotective in
reovirus infections. Thus, the role of Bmp agonists in neurotrophic MV infections may shed
light into the mechanisms of viral control in CD46+/RAG2-KO compared to CD46+ neonates.
Hence, a better understanding of neonatal immunity will lead to effective therapeutic strategies
and enable us to design better vaccines to protect the fetus, mother, and newborns.
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